Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Prostate Cancer,2017,NCI,5R01CA172603-05,,A novel strategy to identify prostate cancer biomarkers for patient management,"HUANG, JIAOTI",DUKE UNIVERSITY,NC,"$329,925"
Prostate Cancer,2017,NIMHD,5R01MD007783-04,,A Health IT based Psychoeducational Intervention for African American Prostate Cancer,"RIVERS, BRIAN",MOREHOUSE SCHOOL OF MEDICINE,GA,"$263,848"
Prostate Cancer,2017,NCI,5R01CA166894-05,,A New Mechanism for Castration Resistant Prostate Cancer,"SUN, ZIJIE",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,$1
Prostate Cancer,2017,NCI,5U01CA194393-03,,Quantifying and Characterizing the shared genetic contribution to common cancers,"LINDSTROEM, SARA",UNIVERSITY OF WASHINGTON,WA,"$566,464"
Prostate Cancer,2017,NCI,5F31CA200163-02,,Determining the mechanisms of selective miRNA packaging for extracellular miRNA secretion in prostate cancer,"HU, TIANYI","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$35,511"
Prostate Cancer,2017,NCI,1K22CA207578-01,,INVESTIGATING THE ROLE OF THE TRANSCRIPTIONAL COREGULATOR SRC-2 IN CASTRATION RESISTANT PROSTATE CANCER,"DASGUPTA, SUBHAMOY",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$206,685"
Prostate Cancer,2017,NCI,5R21CA191913-02,,"Auger Electron Radiotherapy of Late-Stage, Castration-Resistant Prostate Cancer using a Brominated Dihydrotestosterone Analogue","VEACH, DARREN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$229,550"
Prostate Cancer,2017,NCI,5R01CA195476-02,,Reproducibility of Hyperpolarized Pyruvate Metabolic Imaging in Prostate Cancer,"KESHARI, KAYVAN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$287,816"
Prostate Cancer,2017,NCI,5R01CA192669-03,,Dual Targeting of AR and HIF1 to promote radiosensitization of prostate cancer,"LARNER, JAMES",UNIVERSITY OF VIRGINIA,VA,"$412,055"
Prostate Cancer,2017,NCI,5K05CA175147-04,,Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention,"STANFORD, JANET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$88,959"
Prostate Cancer,2017,NCI,5R01CA193331-02,,"Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination thru Engagement in Mindfulness Education (REASSURE ME)","VICTORSON, DAVID",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$513,284"
Prostate Cancer,2017,NCI,5R01CA181605-04,,Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$351,588"
Prostate Cancer,2017,NIGMS,5R01GM112846-03,,Multivalent higher-order complexes regulate ubiquitination in Hedgehog signaling,"MITTAG, TANJA",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$310,984"
Prostate Cancer,2017,NCI,5R21CA195313-02,,Magi2 in aggressive prostate cancer,"MARKER, PAUL",UNIVERSITY OF WISCONSIN-MADISON,WI,"$195,054"
Prostate Cancer,2017,NCI,5R01CA190636-02,,Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery,"NELSON, CHRISTIAN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$693,571"
Prostate Cancer,2017,NCI,5R01CA201430-02,,p53 Variants in Cancer Risk and Therapy,"MURPHY, MAUREEN",WISTAR INSTITUTE,PA,"$421,358"
Prostate Cancer,2017,NCI,5K07CA166462-05,,Impact of Cancer on Adherence in Diabetes,"LIN, JENNY",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$167,805"
Prostate Cancer,2017,NCI,5R01CA193739-02,,Novel targeted chemo/immunotherapy approach for localized and metastatic CaP,"BHAT, MOHAMMAD SALEEM",UNIVERSITY OF MINNESOTA,MN,"$354,563"
Prostate Cancer,2017,NCI,5R01CA101753-13,,Anticarcinogenic Effect of ITCs Against Prostate Cancer,"SINGH, SHIVENDRA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$346,500"
Prostate Cancer,2017,NCI,5R01CA181242-03,,Identification of DNA methylation markers for risk of metastasis in localized pro,"CHAO, CHUN",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$566,816"
Prostate Cancer,2017,NCI,5R01CA200844-02,,Lipid-dendrimer micellar nanocarriers for siRNA/drug co-delivery in MDR cancer,"TORCHILIN, VLADIMIR",NORTHEASTERN UNIVERSITY,MA,"$341,201"
Prostate Cancer,2017,NCI,5R01CA200787-02,,Development of small molecules for ERG ablation in prostate cancer,"KITTLER, RALF",UT SOUTHWESTERN MEDICAL CENTER,TX,"$370,575"
Prostate Cancer,2017,NCI,5R01CA200611-02,,Developing therapeutics against resistance to the androgen-deprivation therapy,"YU, QIN",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$387,731"
Prostate Cancer,2017,NCI,5R01CA193829-02,,Prostate-Specific Androgen Transporters are the Missing Target for Complete ADT,"SMITH, GARY",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$392,306"
Prostate Cancer,2017,NIBIB,5R01EB016707-04,,Protein Biomarker Arrays for Personalized Treatment of Prostate Cancer,"RUSLING, JAMES",UNIVERSITY OF CONNECTICUT STORRS,CT,"$348,141"
Prostate Cancer,2017,NCI,5R01CA172220-05,,Estrogen Receptors in Human Prostate Stem-Progenitor Cells,"PRINS, GAIL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$330,527"
Prostate Cancer,2017,NCI,5R01CA190289-03,,Compensatory steroidogenesis mechanisms in castration-resistant prostate cancer,"SHARIFI, NIMA",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$362,569"
Prostate Cancer,2017,NCI,5R01CA183929-03,,Molecular mechanisms of prostate cancer metastasis,"ABATE-SHEN, CORY",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$366,000"
Prostate Cancer,2017,NCI,5R44CA192701-03,,NanoCytology to mitigate overdiagnosis of prostate cancer,"SUBRAMANIAN, HARIHARAN","NANOCYTOMICS, LLC",IL,"$782,124"
Prostate Cancer,2017,NCI,5R01CA176401-04,,RB Function in Prostate Cancer Progression,"KNUDSEN, KAREN",THOMAS JEFFERSON UNIVERSITY,PA,"$431,269"
Prostate Cancer,2017,NCI,5R00CA175291-04,,CD117 Signaling as a Mechanism of Prostate Cancer Metastasis,"KERR, BETHANY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$249,000"
Prostate Cancer,2017,NCI,5R01CA070297-19,,Androgen Signaling in prostate cancer progression and CRPC development,"SUN, ZIJIE",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,$1
Prostate Cancer,2017,NCI,5R01CA196232-02,,Effectors of protein kinase C-mediated tumor progression,"KAZANIETZ, MARCELO",UNIVERSITY OF PENNSYLVANIA,PA,"$389,662"
Prostate Cancer,2017,NCI,5R01CA136924-08,,Prostate Cancer Risk Enhancers,"FARNHAM, PEGGY",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$556,779"
Prostate Cancer,2017,NIGMS,5R01GM110019-03,,Molecular mechanism of mTORC1-dependent translation and ribosome biogenesis,"INOKI, KEN",UNIVERSITY OF MICHIGAN,MI,"$289,468"
Prostate Cancer,2017,NCI,5R21CA202552-02,,Comparative Effectiveness of Genomics Assay for Active Surveillance Failure Prediction in African American Men:  the impact of genetic ancestry and socioeconomic status.,"MURPHY, ADAM",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$174,014"
Prostate Cancer,2017,NCI,5R01CA174206-05,,Bioinformatics Tools for Genomic Analysis of Tumor and Stromal Pathways in Cancer,"PARMIGIANI, GIOVANNI",DANA-FARBER CANCER INST,MA,"$324,548"
Prostate Cancer,2017,NCI,5K22CA174841-03,,PSMA Targeted Docetaxel Loaded Magnetic Nanoparticles for Prostate Cancer Therapy,"YALLAPU, MURALI",UNIVERSITY OF TENNESSEE HEALTH SCI CTR,TN,"$160,992"
Prostate Cancer,2017,NCI,5R01CA181189-04,,Functional Role of Bone Marrow Adipocytes in Metastatic Prostate Cancer,"PODGORSKI, IZABELA",WAYNE STATE UNIVERSITY,MI,"$315,400"
Prostate Cancer,2017,NCI,5P30CA008748-51,7555,Antitumor,"DE STANCHINA, ELISA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$253,618"
Prostate Cancer,2017,NCI,5P30CA008748-51,7564,Organic Sythesis,"OUERFELLI, OUATHEK",SLOAN-KETTERING INST CAN RESEARCH,NY,"$342,882"
Prostate Cancer,2017,NCI,5P30CA008748-51,7575,Web Survey Core,"VICKERS, ANDREW",SLOAN-KETTERING INST CAN RESEARCH,NY,"$166,422"
Prostate Cancer,2017,NCI,5P30CA008748-51,7582,Bioinfomatics,"SOCCI, NICHOLAS",SLOAN-KETTERING INST CAN RESEARCH,NY,"$828,317"
Prostate Cancer,2017,NCI,5R00CA160640-05,,Tracing the origins of chromosomal translocations in prostate cancer,"MANI, RAM",UT SOUTHWESTERN MEDICAL CENTER,TX,"$249,000"
Prostate Cancer,2017,NCI,5R01CA190554-03,,Osteocytes in prostate cancer bone metastasis,"KELLER, EVAN",UNIVERSITY OF MICHIGAN,MI,"$354,563"
Prostate Cancer,2017,NCI,5R01CA184208-03,,Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer,"FRIGO, DANIEL",UNIVERSITY OF HOUSTON,TX,"$349,759"
Prostate Cancer,2017,NIBIB,5R01EB020353-02,,Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation,"BASILION, JAMES",CASE WESTERN RESERVE UNIVERSITY,OH,"$664,240"
Prostate Cancer,2017,NCI,5R01CA200718-02,,A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials,"EGGLY, SUSAN",WAYNE STATE UNIVERSITY,MI,"$599,514"
Prostate Cancer,2017,NCI,5R00CA175290-05,,An integrated approach to dissect the functional network of large non-coding RNA,"CHEN, YIWEN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$221,939"
Prostate Cancer,2017,NCI,5R01CA202690-02,,Circadian Disruption and Risk of Prostate Cancer in a Multiethnic Cohort,"MUCCI, LORELEI",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$393,034"
Prostate Cancer,2017,NIGMS,1SC2GM121185-01,,Development of Stabilized Zampanolide Mimics as Chemotherapeutics for Prostate Cancer,"CHEN, QIAOHONG",CALIFORNIA STATE UNIVERSITY FRESNO,CA,"$140,000"
Prostate Cancer,2017,NCI,2P30CA006516-52,5398,Program 3: Prostate Cancer,"BALK, STEVEN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$40,304"
Prostate Cancer,2017,NCI,5R01CA202814-02,,Diagnosis and longitudinal monitoring of metastatic prostate cancer through molecular MR imaging,"STEINMETZ, NICOLE",CASE WESTERN RESERVE UNIVERSITY,OH,"$394,519"
Prostate Cancer,2017,NCI,2P30CA012197-42,6112,Tumor Progression and Recurrence (01),"PASCHE, BORIS",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$49,492"
Prostate Cancer,2017,NCI,5R01CA183857-04,,Exploiting drivers of androgen receptor signaling negative prostate cancer for pr,"TOMLINS, SCOTT",UNIVERSITY OF MICHIGAN,MI,"$321,625"
Prostate Cancer,2017,NCI,5R21CA202214-02,,Detection of High Grade Prostate Cancer with Subharmonic Ultrasound Imaging,"HALPERN, ETHAN",THOMAS JEFFERSON UNIVERSITY,PA,"$206,883"
Prostate Cancer,2017,NCI,5R01CA168601-05,,Novel roles of microRNA in androgen receptor signaling,"GAO, ALLEN",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$308,025"
Prostate Cancer,2017,NCI,5R35CA197465-02,,Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance,"RONAI, ZE'EV",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$1,137,453"
Prostate Cancer,2017,NCI,5R35CA197684-02,,"IKK/NF-kappaB Signaling in Cancer:  Therapy, Resistance, and Tumor Initiating Cells","BALDWIN, ALBERT",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$848,325"
Prostate Cancer,2017,NIBIB,5R03EB022141-02,,Towards an Effective Prostate Cancer-Targeting Biomaterial,"CONDA SHERIDAN, MARTIN",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$75,250"
Prostate Cancer,2017,NCI,1R01CA212094-01,,Inhibition of castration resistant prostate cancer by targeting of the IKKbeta/AR signaling,"DAN, HANCAI",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$366,943"
Prostate Cancer,2017,NCI,1R01CA211646-01,,Assays to Identify Prostate Cancer Therapeutics Targeting Antizyme Inhibitor,"ZETTER, BRUCE",BOSTON CHILDREN'S HOSPITAL,MA,"$415,154"
Prostate Cancer,2017,NCI,5R01CA157429-05,,Overcoming drug resistance of castration-resistant prostate cancer,"LIU, XIAOQI",PURDUE UNIVERSITY,IN,"$257,688"
Prostate Cancer,2017,NCI,5R01CA182435-03,,Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis,"DATTA, KAUSTUBH",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$344,269"
Prostate Cancer,2017,NCI,5R01CA192894-02,,Enhancing anti-neoplastic activity of metformin in prostate cancer,"LIU, XIAOQI",PURDUE UNIVERSITY,IN,"$357,624"
Prostate Cancer,2017,NIGMS,5R01GM111084-03,,Structural and Mechanistic Studies of the Mitochondrial Protein Folding Machinery,"TSAI, FRANCIS",BAYLOR COLLEGE OF MEDICINE,TX,"$340,642"
Prostate Cancer,2017,NCI,5R01CA183965-04,,Role of TOP2B in generating complex genomic rearrangements in human cancer,"YEGNASUBRAMANIAN, SRINIVASAN",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Prostate Cancer,2017,NCI,5R01CA200551-02,,A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR,"PARK, SEAN",MAYO CLINIC ROCHESTER,MN,"$247,249"
Prostate Cancer,2017,NCI,5R01CA160902-06,,Advancement and Validation of Prostate Diffusion and Spectroscopic MRI,"MAIER, STEPHAN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$220,860"
Prostate Cancer,2017,NCI,1K99CA212292-01,,Elucidating a Novel Mechanism for SPOP in Suppressing Prostate Tumorigenesis,"ZHANG, JINFANG",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$168,804"
Prostate Cancer,2017,NCI,1R21CA212516-01,,Enhancing Survivorship Care Planning for Patients with Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program,"SONG, LIXIN",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$198,360"
Prostate Cancer,2017,NCI,1R21CA213020-01,,Hyperpolarized 13C imaging of mitochondrial metabolism for improved characterization of prostate cancer,"MAYER, DIRK",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$167,702"
Prostate Cancer,2017,NCI,5R01CA176844-05,,The Hippo Pathway in Prostate Gland Homeostasis and Prostate Cancer,"VASIOUKHIN, VALERI",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$362,148"
Prostate Cancer,2017,NCI,5R01CA178431-04,,Function of the Stem Cell Transcription Factor Sox2 in Prostate Cancer,"VANDER GRIEND, DONALD",UNIVERSITY OF CHICAGO,IL,"$323,229"
Prostate Cancer,2017,NCI,1R21CA213157-01,,Radiolabeled FASN Inhibitors for PET Imaging,"BABICH, JOHN",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$229,013"
Prostate Cancer,2017,NCI,5R01CA169524-05,,Role of RNF6 in survival signaling,"QIU, YUN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$318,513"
Prostate Cancer,2017,NCI,5R01CA186780-22,,Roles of EAF2 in androgen action in the prostate,"WANG, ZHOU",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$371,525"
Prostate Cancer,2017,NCI,5R01CA112226-08,,Transcription repression in prostate cancer,"LOGAN, SUSAN",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$402,563"
Prostate Cancer,2017,NCI,5R01CA193910-03,,Defining the epigenetic landscape in human prostate cancer,"FREEDMAN, MATTHEW",DANA-FARBER CANCER INST,MA,"$633,613"
Prostate Cancer,2017,NCI,1R03CA212556-01,,Loss of novel end joining factor with dysfunction of BRCA1 contributes to treatment resistance,"TOMIDA, JUNYA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$80,000"
Prostate Cancer,2017,NCI,1R03CA212567-01,,the role of EZH2 in neuroendocrine prostate cancer,"YU, XIUPING",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$72,500"
Prostate Cancer,2017,NCI,1R15CA202984-01A1,,Oncolytic reovirus modulation of the cancer cell hypoxic response,"MILLER, CATHY",IOWA STATE UNIVERSITY,IA,"$441,245"
Prostate Cancer,2017,NCI,5F30CA196108-03,,Functional Investigation of the Mitochondrial Pyruvate Carrier in Prostate Cancer,"BADER, DAVID",BAYLOR COLLEGE OF MEDICINE,TX,"$38,455"
Prostate Cancer,2017,NCI,5R01CA127923-10,,IKK   and the Control of Prostate Cancer Metastasis,"KARIN, MICHAEL",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$257,099"
Prostate Cancer,2017,NCI,5R01CA174798-05,,Endothelial-to-osteoblast transition in prostate cancer bone metastasis,"LIN, SUE-HWA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$88,988"
Prostate Cancer,2017,NCI,5R01CA172576-04,,Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents,"CHEN, CHING-SHIH",OHIO STATE UNIVERSITY,OH,"$319,550"
Prostate Cancer,2017,NCI,2R01CA105304-11A1,,Delineating the mechanisms of androgen receptor activation function-1 antagonists for development of novel prostate cancer therapeutics,"SADAR, MARIANNE",BRITISH COLUMBIA CANCER AGENCY,CANADA,"$260,847"
Prostate Cancer,2017,NCI,5R01CA197516-02,,3D Prostate Histochemometry to Predict Disease Recurrence,"BHARGAVA, ROHIT",UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,IL,"$400,626"
Prostate Cancer,2017,NCI,5K23CA197526-02,,Overcoming drug resistance in metastatic castration resistant prostate cancer with a novel combination of TGF-beta inhibition and enzalutamide,"PALLER, CHANNING",JOHNS HOPKINS UNIVERSITY,MD,"$177,120"
Prostate Cancer,2017,NCI,1R01CA201035-01A1,,Kallikrein-Targeted Alpha-Particle Therapy of Late-Stage Prostate Cancer,"THOREK, DANIEL",JOHNS HOPKINS UNIVERSITY,MD,"$373,340"
Prostate Cancer,2017,NCI,1R01CA203930-01A1,,Biobehavioral Effects of Qigong for Prostate Cancer Survivors with Fatigue,"KINNEY, ANITA",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$623,021"
Prostate Cancer,2017,NCI,5R01CA204430-02,,Mitochondria in Prostate Cancer Diversity,"SINGH, KESHAV",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$336,263"
Prostate Cancer,2017,NCI,1R01CA204254-01A1,,Academic-Industrial Partnership for Translation of PET/TRUS Guided Intervention,"FEI, BAOWEI",EMORY UNIVERSITY,GA,"$376,753"
Prostate Cancer,2017,NCI,5R21CA194798-02,,Exploring high-does testosterone as a potential treatment for abiraterone-resistant prostate cancer,"COREY, EVA",UNIVERSITY OF WASHINGTON,WA,"$201,623"
Prostate Cancer,2017,NCI,5R21CA197887-02,,Autophagy regulation of prostate tumor development,"THORBURN, ANDREW",UNIVERSITY OF COLORADO DENVER,CO,"$169,106"
Prostate Cancer,2017,NCI,1R01CA206592-01A1,,Structural Mechanisms of Hedgehog Autoprocessing in Physiology and Disease,"WANG, CHUNYU",RENSSELAER POLYTECHNIC INSTITUTE,NY,"$400,728"
Prostate Cancer,2017,NIDDK,1R01DK109314-01A1,,The microtubule cytoskeleton as a novel target for cavernous nerve regeneration after prostatectomy,"DAVIES, KELVIN","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$578,367"
Prostate Cancer,2017,NCI,5R01CA206222-02,,Targeting key orphan nuclear receptor in lethal prostate cancer,"CHEN, HONGWU",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$359,138"
Prostate Cancer,2017,NIEHS,5R01ES014032-08,,Cancer in adults following in utero and early life exposure to arsenic,"STEINMAUS, CRAIG",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$443,807"
Prostate Cancer,2017,NCI,5K08CA175154-06,,Defining the role of eIF4F in metastatic castration resistant prostate cancer,"HSIEH, ANDREW",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$169,560"
Prostate Cancer,2017,NCI,2U01CA167552-06,,Cancer Epidemiology Cohort in Male Health Professionals,"WILLETT, WALTER",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$1,884,447"
Prostate Cancer,2017,NCI,5R01CA125535-10,,Mechanism of beta-Catenin and APC-Regulated Transcription at Wnt Target Genes,"JONES, KATHERINE",SALK INSTITUTE FOR BIOLOGICAL STUDIES,CA,"$452,288"
Prostate Cancer,2017,NCI,5R01CA193837-03,,Defining the Role of ERG in Modulating the AR Cistrome and Antiandrogen Sensitivity,"SAWYERS, CHARLES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$468,128"
Prostate Cancer,2017,NCI,5R01CA181802-04,,Effect of Aerobic Exercise  on Genomic Signatures of Prostate Cancer Prognosis,"CHAN, JUNE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$627,846"
Prostate Cancer,2017,NCI,5R00CA184397-04,,Proteolytically Cleaved Receptors as Oncogenes and Therapeutic Targets,"STOYANOVA, TANYA",STANFORD UNIVERSITY,CA,"$242,996"
Prostate Cancer,2017,NCI,5F30CA203472-02,,Clinical bacterial isolate engineered as an immunotherapy for prostate cancer,"ANKER, JONATHAN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$49,044"
Prostate Cancer,2017,NCI,5R01CA191002-02,,The role of PLK1 in prostate cancer,"FU, ZHENG",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$348,844"
Prostate Cancer,2017,NCI,5R21CA199171-02,,Genetic Signatures Underlying Prostate Cancer Metastasis in AfricanAmericans,"FARUQUE, MEZBAH",HOWARD UNIVERSITY,DC,"$131,370"
Prostate Cancer,2017,NCI,5R01CA123484-10,,Role of Oncogenic Kinase Pim-1 in Prostate Cancer,"ABDULKADIR, SARKI",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$284,744"
Prostate Cancer,2017,NCI,5R01CA168899-05,,Cooperative steroidogenic inhibition for treatment of advanced prostate cancer,"SHARIFI, NIMA",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$326,897"
Prostate Cancer,2017,NCI,5R01CA193481-03,,Sequence-specific Capture for Discovering Protein-IncRNA Interactions in Prostate Cancer,"SMITH, LLOYD",UNIVERSITY OF WISCONSIN-MADISON,WI,"$344,168"
Prostate Cancer,2017,NIGMS,5R01GM086596-07,,Activation of androgen biosynthesis and drug metabolism by cytochrome b5,"AUCHUS, RICHARD",UNIVERSITY OF MICHIGAN,MI,"$338,571"
Prostate Cancer,2017,NCI,5R01CA174777-05,,AR Gene Rearrangements and AR Signaling in Prostate Cancer,"DEHM, SCOTT",UNIVERSITY OF MINNESOTA,MN,"$310,149"
Prostate Cancer,2017,NCI,5R01CA171189-05,,Bidirectional role of KLF5 in prostatic epithelial homeostasis and tumorigenesis,"DONG, JIN-TANG",EMORY UNIVERSITY,GA,"$323,700"
Prostate Cancer,2017,NCI,5R44CA203199-02,,Novel Androgen Receptor Degraders to Treat Castration-Resistant Prostate Cancer,"TAYLOR, IAN","ARVINAS, INC.",CT,"$402,226"
Prostate Cancer,2017,NCI,5K99CA194289-02,,MDSC-tumor crosstalk in prostate cancer progression and castration resistance,"WANG, GUOCAN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$104,445"
Prostate Cancer,2017,NCI,5F30CA203517-02,,Role of Neutrophil Elastase in Castration-Sensitive and Resistant Prostate Cancer,"LERMAN, IRINA",UNIVERSITY OF ROCHESTER,NY,"$49,044"
Prostate Cancer,2017,NCI,5R01CA125612-09,,Towards Understanding Prostate Cancer Heterogeneity,"RUBIN, MARK",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$372,410"
Prostate Cancer,2017,NCI,5R01CA157372-06,,VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer,"THAKUR, MATHEW",THOMAS JEFFERSON UNIVERSITY,PA,"$380,300"
Prostate Cancer,2017,NCI,5R01CA176671-05,,Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET,"LEWIS, JASON",SLOAN-KETTERING INST CAN RESEARCH,NY,"$563,930"
Prostate Cancer,2017,NCI,5R21CA196570-02,,Reprogramming of Prostate Stromal Cells by Prostate Inflammation,"XIN, LI",BAYLOR COLLEGE OF MEDICINE,TX,"$185,247"
Prostate Cancer,2017,NCI,5R01CA115746-10,,Characterizing Prostate Cancer By ex vivo MRS Signatures,"CHENG, LEO",MASSACHUSETTS GENERAL HOSPITAL,MA,"$556,388"
Prostate Cancer,2017,NCI,5R01CA187918-03,,Targeting the p110beta isoform of PI3 kinase in prostate cancer,"ROBERTS, THOMAS",DANA-FARBER CANCER INST,MA,"$554,053"
Prostate Cancer,2017,NCI,5R00CA181342-04,,Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy,"LIU, PENGDA",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$217,518"
Prostate Cancer,2017,NCI,5R01CA197944-02,,Development of cancer therapeutic TBK1/IKKi dual inhibitors,"LUO, JUN-LI",SCRIPPS FLORIDA,FL,"$439,200"
Prostate Cancer,2017,NCI,5R01CA205400-02,,Distinct Redox Mechanism in Normal and Cancer Cells as a Novel Therapeutic Target,"ST CLAIR, DARET",UNIVERSITY OF KENTUCKY,KY,"$339,072"
Prostate Cancer,2017,NCI,5R01CA188015-03,,Discovery of Selective MAP2K4 Inhibitors to Target Metastasis,"SCHEIDT, KARL",NORTHWESTERN UNIVERSITY,IL,"$346,802"
Prostate Cancer,2017,NCI,5R01CA188427-03,,Regulation of tyrosine kinase signaling through interaction with membrane lipids,"TYNER, ANGELA",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$430,308"
Prostate Cancer,2017,NCI,5K99CA197804-02,,Epigenetic Mechanisms Controlling T-cell Exhaustion in Prostate Cancer,"KISSICK, HAYDN",EMORY UNIVERSITY,GA,"$111,730"
Prostate Cancer,2017,NCI,5R01CA172384-05,,The Role of NOV (CCN3) in Prostate Cancer Progression,"YU, JINDAN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$320,588"
Prostate Cancer,2017,NIDDK,5R01DK092202-07,,Prostate Epithelial Lineage Hierarchy,"XIN, LI",BAYLOR COLLEGE OF MEDICINE,TX,"$356,625"
Prostate Cancer,2017,NIMHD,5R01MD008934-04,,Decision Aids to Address Prostate Cancer Disparities in Minority Men,"TILBURT, JON",MAYO CLINIC ROCHESTER,MN,"$358,055"
Prostate Cancer,2017,NCI,5R01CA198097-02,,Co-targeting oncogenic pathways in advanced prostate cancer,"CICHOWSKI, KAREN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$381,212"
Prostate Cancer,2017,NCI,5R01CA200859-02,,Hardwiring Mechanism into Predicting Cancer Phenotypes by Computational Learning,"MARCHIONNI, LUIGI",JOHNS HOPKINS UNIVERSITY,MD,"$384,981"
Prostate Cancer,2017,NCI,5R01CA189765-03,,CXCL13: a mediator of prostate cancer progression,"KAZANIETZ, MARCELO",UNIVERSITY OF PENNSYLVANIA,PA,"$356,098"
Prostate Cancer,2017,NCI,1F32CA213742-01,,Establishing in vitro carcinoma models of the Alternative Lengthening of Telomeres pathway to elucidate molecular mechanisms and identify therapeutic vulnerabilities,"GRAHAM, MINDY",JOHNS HOPKINS UNIVERSITY,MD,"$57,066"
Prostate Cancer,2017,NCI,5R01CA154387-05,,Inhibiting serine protease-induced prostate cancer progression,"RADISKY, EVETTE",MAYO CLINIC  JACKSONVILLE,FL,"$325,287"
Prostate Cancer,2017,NIGMS,5SC1CA180212-05,,Role of CCL25-CCR9 in Prostate Cancer,"SINGH, SHAILESH",MOREHOUSE SCHOOL OF MEDICINE,GA,"$353,750"
Prostate Cancer,2017,NCI,1F31CA203036-01A1,,Bone Marrow Adipocytes Alter the Metabolic Phenotype of Metastatic Prostate Cancer Cells Through the Activation of HIF-1a,"DIEDRICH, JONATHAN",WAYNE STATE UNIVERSITY,MI,"$28,447"
Prostate Cancer,2017,NCI,5U01CA113913-12,,"Emory, Harvard & Univ. of Washington Prostate Cancer Biomarker Center","SANDA, MARTIN",EMORY UNIVERSITY,GA,"$874,523"
Prostate Cancer,2017,NCI,5R01CA123362-06,,PDGF D and Prostate Cancer Bone Metastasis,"KIM, HYEONG-REH",WAYNE STATE UNIVERSITY,MI,"$354,346"
Prostate Cancer,2017,NCI,5R01CA175779-05,,Phosphatidylserine Targeted Tumor Cell Lytic Peptoids,"UDUGAMASOORIYA, DAMITH",UNIVERSITY OF HOUSTON,TX,"$281,989"
Prostate Cancer,2017,NCI,5U01CA185490-04,,Molecular determinant of racial disparity in prostate cancer,"SINGH, AJAY",UNIVERSITY OF SOUTH ALABAMA,AL,"$314,363"
Prostate Cancer,2017,NINR,1R01NR016483-01A1,,Decision Navigation for Advanced Prostate Cancer Treatment Options using mHealth,"JONES, RANDY",UNIVERSITY OF VIRGINIA,VA,"$491,732"
Prostate Cancer,2017,NCI,5R01CA185297-03,,The aberrant androgen receptor underlies abiraterone/enzalutamide resistance,"LUO, JUN",JOHNS HOPKINS UNIVERSITY,MD,"$370,575"
Prostate Cancer,2017,NCI,5P30CA016087-37,6482,GENITOURINARY CANCERS,"CARROLL, WILLIAM",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$27,088"
Prostate Cancer,2017,NCI,5U24CA115102-12,,Clinical and Analytical Validation of Cancer Biomarkers,"CHAN, DANIEL",JOHNS HOPKINS UNIVERSITY,MD,"$486,000"
Prostate Cancer,2017,NCI,5R21CA205108-02,,A Small-Molecule Inhibitor of the Terminal Steps for Intracrine Androgen Synthesis in Advanced Prostate Cancer,"MOHLER, JAMES",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$259,734"
Prostate Cancer,2017,NCI,9R13MD011368-04,,African Caribbean Cancer Consortium Scientific and Training Conference,"RAGIN, CAMILLE",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$24,000"
Prostate Cancer,2017,NIMHD,9R13MD011368-04,,African Caribbean Cancer Consortium Scientific and Training Conference,"RAGIN, CAMILLE",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$50,000"
Prostate Cancer,2017,NCI,5U01CA152813-07,,Glycoprotein Biomarkers for  Early Detection of Aggressive Prostate Cancer,"ZHANG, HUI",JOHNS HOPKINS UNIVERSITY,MD,"$549,721"
Prostate Cancer,2017,NCI,5R01CA184228-04,,Small Molecule PSMA-Targeted Alpha Therapy,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$418,621"
Prostate Cancer,2017,NCI,5R01CA178338-04,,Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer,"GIOELI, DANIEL",UNIVERSITY OF VIRGINIA,VA,"$327,850"
Prostate Cancer,2017,NCI,5R01CA183882-03,,HCS to Identify Inhibitors and Disruptors of AR-TIF2 Interactions,"JOHNSTON, PAUL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$338,926"
Prostate Cancer,2017,NCI,5R01CA172169-05,,PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUM,"LU, JUNXUAN",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$90,971"
Prostate Cancer,2017,NCI,5R01CA179100-04,,Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis,"RICKMAN, DAVID",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$428,881"
Prostate Cancer,2017,NCI,5R01CA204786-02,,Modulation of host intrinsic immunity to reduce prostate cancer disparity,"KARAN, DEV",UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA,SC,$1
Prostate Cancer,2017,NCI,5R01CA193678-02,,Hemostatic Factors Drive Prostate Cancer Pathogenesis,"PALUMBO, JOSEPH",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$356,850"
Prostate Cancer,2017,NCI,5R01CA184012-04,,Bipolar Androgen Therapy for Progressive Castrate Resistant Prostate Cancer,"DENMEADE, SAMUEL",JOHNS HOPKINS UNIVERSITY,MD,"$261,450"
Prostate Cancer,2017,NCI,5R01CA196947-02,,Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery,"FIGUEIREDO, MARXA",PURDUE UNIVERSITY,IN,"$350,644"
Prostate Cancer,2017,NCI,5F32CA196080-02,,Investigating the role of autophagy in Tak1 null prostate cancer and TRAIL sensitivity,"GOODALL, MEGAN",UNIVERSITY OF COLORADO DENVER,CO,"$59,166"
Prostate Cancer,2017,NCI,5R01CA179129-05,,Bone metabolism and bone metastases in prostate cancer,"WILSON, KATHRYN",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$207,639"
Prostate Cancer,2017,NCI,5R01CA132641-19,,The Biology of Prostate Stem Cells - Resubmission - 1,"WILSON, ELAINE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$394,769"
Prostate Cancer,2017,NCI,5U54CA193313-03,7218,Project 1: Modeling tumor evolution in mouse and organoid models,"RABADAN, RAUL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$398,421"
Prostate Cancer,2017,NCI,5R21CA205257-02,,The Role of Mitochondrial Heterogeneity in Pyruvate Flux in Prostate Cancer Progression,"MCGUIRE, SEAN",BAYLOR COLLEGE OF MEDICINE,TX,"$172,369"
Prostate Cancer,2017,NCI,1R41CA214080-01,,Anti-CCL25 mAb to treat castration resistant prostate cancer,"SINGH, SHAILESH","JYANT, INC.",GA,"$350,000"
Prostate Cancer,2017,NCI,5R01CA199741-03,,CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer,"CRAMER, SCOTT",UNIVERSITY OF COLORADO DENVER,CO,"$341,879"
Prostate Cancer,2017,NCI,5R01CA177984-04,,MicroRNAs in frequently deleted loci regulate prostate cancer EMT and metastasis,"SAINI, SHARANJOT",NORTHERN CALIFORNIA INSTITUTE/RES/EDU,CA,"$383,250"
Prostate Cancer,2017,NCI,5R01CA192402-03,,Estimating Overdiagnosis in Cancer Screening Studies,"ETZIONI, RUTH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$614,029"
Prostate Cancer,2017,NCI,5R01CA197996-02,,Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.,"SMIRAGLIA, DOMINIC",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$389,441"
Prostate Cancer,2017,NCI,5R01CA169300-05,,Targeting Cathepsin L: A Novel Strategy to Impede Prostate and Breast Cancer Meta,"SIEMANN, DIETMAR",UNIVERSITY OF FLORIDA,FL,"$311,250"
Prostate Cancer,2017,NCI,5P01CA098912-13,8454,Core A: Biostatistics and Bioinformatics Core,"TIGHIOUART, MOURAD",CEDARS-SINAI MEDICAL CENTER,CA,"$121,627"
Prostate Cancer,2017,NCI,5P01CA098912-13,8455,Core B: Pathology and High-resolution Imaging Core,"ZAYZAFOON, MAJD",CEDARS-SINAI MEDICAL CENTER,CA,"$168,654"
Prostate Cancer,2017,NCI,5P01CA098912-13,8456,Project 1: Molecular Mechanisms Initiating Prostate Cancer Metastasis,"CHUNG, LELAND",CEDARS-SINAI MEDICAL CENTER,CA,"$282,822"
Prostate Cancer,2017,NCI,5P01CA098912-13,8457,Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis,"FARACH-CARSON, MARY",RICE UNIVERSITY,TX,"$281,091"
Prostate Cancer,2017,NCI,5P01CA098912-13,8458,Project 3: Prostatic Epithelial Stromal Interactions Facilitate Bone Metastasis,"BHOWMICK, NEIL",CEDARS-SINAI MEDICAL CENTER,CA,"$283,400"
Prostate Cancer,2017,NCI,5P01CA098912-13,8459,Project 4: Cholesterol Metabolism and Prostate Cancer Metastasis,"FREEMAN, MICHAEL",CEDARS-SINAI MEDICAL CENTER,CA,"$258,344"
Prostate Cancer,2017,NCI,5P01CA098912-13,8460,Program Integration and Management,"CHUNG, LELAND",CEDARS-SINAI MEDICAL CENTER,CA,"$55,758"
Prostate Cancer,2017,NCI,5R01CA168393-04,,SOX9 Mediation of AR and ERG Driven Prostate Cancer,"BALK, STEVEN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$361,050"
Prostate Cancer,2017,NCI,5R01CA206189-02,,Nanoparticle-mediated treatment for bone metastasis,"LABHASETWAR, VINOD",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$312,562"
Prostate Cancer,2017,NCI,5R01CA173481-05,,Preclinical analyses of advanced prostate cancer in genetically-engineered mice,"ABATE-SHEN, CORY",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$389,781"
Prostate Cancer,2017,NCI,5U01CA185148-03,,MIC-1 and its functional partners in prostate cancer racial disparity,"BATRA, SURINDER",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$312,080"
Prostate Cancer,2017,NCI,5F30CA192896-03,,IL-1b-mediated tumor-stromal interaction and prostate cancer cell cooperation in the bone metastatic niche,"SHAHRIARI, KRISTINA",DREXEL UNIVERSITY,PA,"$49,044"
Prostate Cancer,2017,NCI,5R00CA166507-05,,Molecular basis of androgen receptor mediated gene transcriptional repression,"CAI, CHANGMENG",UNIVERSITY OF MASSACHUSETTS BOSTON,MA,"$237,796"
Prostate Cancer,2017,NCI,5P30CA016056-40,8364,Genitourinary Cancers Program,"TRUMP, DONALD",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$70,515"
Prostate Cancer,2017,NCI,5P30CA016056-40,8380,Mouse Tumor Model Shared Resource,"TRUMP, DONALD",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$102,861"
Prostate Cancer,2017,NCI,5R01CA172801-05,,Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards,"KARCZMAR, GREGORY",UNIVERSITY OF CHICAGO,IL,"$465,411"
Prostate Cancer,2017,NCI,5R01CA174714-05,,The role of IL-17 in prostate cancer,"YOU, ZONGBING",TULANE UNIVERSITY OF LOUISIANA,LA,"$312,288"
Prostate Cancer,2017,NIGMS,5P20GM109091-04,8002,Targeting COPZl in miR-152 deficient tumor cells,"SHTUTMAN, MICHAEL",UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA,SC,"$217,202"
Prostate Cancer,2017,NINR,5K01NR015246-03,,Mitochondrial Bioenergetic Mechanism of Cancer Related Fatigue,"HSIAO, CHAO-PIN",CASE WESTERN RESERVE UNIVERSITY,OH,"$90,990"
Prostate Cancer,2017,NIBIB,5R01EB019288-04,,Polymeric nanoparticles with imaging capability for therapeutic peptide delivery,"PEREZ, J",CEDARS-SINAI MEDICAL CENTER,CA,"$292,627"
Prostate Cancer,2017,NCI,5R01CA179059-04,,Enhancement of BB2r-Targeted Radiotherapy for Prostate Cancer Utilizing Hypoxia-S,"GARRISON, JERED",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$312,288"
Prostate Cancer,2017,NINR,5R01NR014502-03,,A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer,"BHASIN, SHALENDAR",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$687,002"
Prostate Cancer,2017,NCI,5R00CA178199-05,,Polycomb -Independent Functions of EZH2 in Castration Resistant Prostate Cancer,"XU, KEXIN",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,$1
Prostate Cancer,2017,NCI,5R01CA025836-37,,Radiopharmaceuticals for Imaging Nuclear Receptors in Breast and Prostate Cancers,"KATZENELLENBOGEN, JOHN",UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,IL,"$420,805"
Prostate Cancer,2017,NCI,2P30CA006973-54,8089,Prostate Cancer Program - 07,"PIENTA, KENNETH",JOHNS HOPKINS UNIVERSITY,MD,"$55,301"
Prostate Cancer,2017,NCI,5R21CA202199-02,,Prostate Specific Membrane Antigen Targeted Photoacoustic Imaging for Prostate Cancer,"RAY, SANGEETA",JOHNS HOPKINS UNIVERSITY,MD,"$189,338"
Prostate Cancer,2017,NCI,5R01CA181654-03,,Small Molecule Activators of PP2A (SMAPs) for Prostate Cancer Therapy,"NARLA, GOUTHAM",CASE WESTERN RESERVE UNIVERSITY,OH,"$374,305"
Prostate Cancer,2017,NCI,5R01CA185509-04,,(PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc,"GHOSH, PARAMITA",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$258,128"
Prostate Cancer,2017,NCI,5R01CA184075-03,,PALS: Prostate Cancer Active Lifestyle Study,"WRIGHT, JONATHAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$610,584"
Prostate Cancer,2017,NCI,5P30CA056036-18,7223,Biology of Prostate Cancer,"KNUDSEN, KAREN",THOMAS JEFFERSON UNIVERSITY,PA,"$27,080"
Prostate Cancer,2017,NCI,5R01CA200573-02,,Characterizing the signaling pathways that regulate Skp2 oncogenic function,"WEI, WENYI",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$395,738"
Prostate Cancer,2017,NCI,5R01CA166440-04,,Towards selective androgen deprivation by targeting androgen activation of SRF,"HEEMERS, HANNELORE",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$149,738"
Prostate Cancer,2017,NCI,5P30CA013696-43,6104,Prostate Cancer Program,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$35,133"
Prostate Cancer,2017,NCI,5R01CA199663-03,,Image-guided radiation-induced permeability (IGRIP) for IGDD,"KRON, STEPHEN",UNIVERSITY OF CHICAGO,IL,"$492,442"
Prostate Cancer,2017,NCI,5R01CA190378-03,,The Notch Signaling in Prostate Homeostasis and Carcinogenesis,"XIN, LI",BAYLOR COLLEGE OF MEDICINE,TX,"$362,569"
Prostate Cancer,2017,NIGMS,5R01GM107427-04,,Utilizing genetic and functional strategies to identify causal genes and alleles,"FREEDMAN, MATTHEW",DANA-FARBER CANCER INST,MA,"$484,483"
Prostate Cancer,2017,NCI,1R01CA214872-01,,Parp Function in Prostate Cancer,"PASCHAL, BRYCE",UNIVERSITY OF VIRGINIA,VA,"$370,478"
Prostate Cancer,2017,NCI,5R01CA201458-02,,Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis,"ZHU, LIANG","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$382,013"
Prostate Cancer,2017,NCI,5R01CA134514-09,,Role of FOXO1 Inactivation in Prostate Tumorigenesis,"HUANG, HAOJIE",MAYO CLINIC ROCHESTER,MN,"$357,750"
Prostate Cancer,2017,NCI,5R01CA187273-03,,Suppression of Prostate Tumor Growth and Metastasis by Inhibition of Vimentin,"RANGNEKAR, VIVEK",UNIVERSITY OF KENTUCKY,KY,"$344,269"
Prostate Cancer,2017,NCI,1R01CA215550-01,,Brain-Selective Therapy to Alleviate Hot Flushes of Prostate Cancer Patients,"PROKAI, LASZLO",UNIVERSITY OF NORTH TEXAS HLTH SCI CTR,TX,"$355,055"
Prostate Cancer,2017,NCI,1R01CA217817-01,,Molecular Probes Shed Light on Magnesium Homeostasis,"BUCCELLA, DANIELA",NEW YORK UNIVERSITY,NY,"$348,180"
Prostate Cancer,2017,NCI,1R01CA214554-01,,CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING,"KURHANEWICZ, JOHN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$684,591"
Prostate Cancer,2017,NCI,5R01CA197160-03,,Neuroendocrine mechanisms of prostate cancer progression,"NIKITIN, ALEXANDER",CORNELL UNIVERSITY,NY,"$348,145"
Prostate Cancer,2017,NCI,5U01CA202958-02,,Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer,"BASANTA GUTIERREZ, DAVID",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$690,824"
Prostate Cancer,2017,NCI,5R01CA193967-02,,The NEDD8 pathway mediated Skp2 degradation in chemoprevention by FKA,"ZI, XIAOLIN",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$353,419"
Prostate Cancer,2017,NCI,5R01CA182569-03,,USP22 Function in Advanced Prostate Cancer,"KNUDSEN, KAREN",THOMAS JEFFERSON UNIVERSITY,PA,"$493,498"
Prostate Cancer,2017,NCI,5F31CA200390-02,,The Ron Receptor in Castration Resistant Prostate Cancer,"BROWN, NICHOLAS",UNIVERSITY OF CINCINNATI,OH,"$33,653"
Prostate Cancer,2017,NCI,5K08CA187417-04,,Genomic instability and DNA repair in a distinct molecular class of prostate canc,"BARBIERI, CHRISTOPHER",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$172,908"
Prostate Cancer,2017,NCI,5R21CA183679-03,,Microfluidic Western Blotting for Targeted Proteomic Analysis of Single Circulating Tumor Cells,"HERR, AMY",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$181,878"
Prostate Cancer,2017,NCI,5R01CA178846-05,,MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES,"SLINGLUFF, CRAIG",UNIVERSITY OF VIRGINIA,VA,"$394,792"
Prostate Cancer,2017,NCI,5P30CA043703-27,5473,TISSUE RESOURCES CORE FACILITY,"GERSON, STANTON",CASE WESTERN RESERVE UNIVERSITY,OH,"$151,408"
Prostate Cancer,2017,NIBIB,5U01EB012493-08,,Point-of care Microfluidics for Early Detection of Cancer,"TONER, MEHMET",MASSACHUSETTS GENERAL HOSPITAL,MA,"$2,082,080"
Prostate Cancer,2017,NCI,5R01CA172495-05,,Targeting myristoylation of Src family kinases for inhibition of prostate tumorig,"CAI, HOUJIAN",UNIVERSITY OF GEORGIA,GA,"$311,250"
Prostate Cancer,2017,NCI,5R01CA197477-02,,Hypoxia: Impact on Src Signaling and Prostate Cancer,"SIEMANN, DIETMAR",UNIVERSITY OF FLORIDA,FL,"$344,053"
Prostate Cancer,2017,NIGMS,5SC2CA200520-03,,Novel Hyperpolarized Agents for Metabolic Imaging of Cancer,"BILLINGSLEY, KELVIN",SAN FRANCISCO STATE UNIVERSITY,CA,$1
Prostate Cancer,2017,NCI,5R01CA185251-04,,[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis,"BEEBE, DAVID",UNIVERSITY OF WISCONSIN-MADISON,WI,"$700,207"
Prostate Cancer,2017,NCI,5R01CA174294-05,,Multifunctional immunoPET tracers for pancreatic and prostate cancer,"WU, ANNA",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$444,176"
Prostate Cancer,2017,NCI,1R01CA204806-01A1,,Consequences and mechanism of aberrant splicing in African American prostate cancer disparities,"LEE, NORMAN",GEORGE WASHINGTON UNIVERSITY,DC,"$376,409"
Prostate Cancer,2017,NCI,5P01CA134294-10,7461,Methods for Comparative Effectiveness Research in Cancer,"HERNAN, MIGUEL",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$220,122"
Prostate Cancer,2017,NCI,5R01CA206456-02,,Culturally Adapted Cognitive Behavioral Stress and Self-Management (C-CBSM) Intervention for PC,"PENEDO, FRANK",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$638,319"
Prostate Cancer,2017,NCI,1R03CA208221-01A1,,Increased chemoprevention by a mixture of three phytochemicals in prostate cancer,"WANG, PIWEN",CHARLES R. DREW UNIVERSITY OF MED & SCI,CA,"$78,526"
Prostate Cancer,2017,NCI,5R21CA198820-02,,Functions of histone variants in castration-resistance prostate cancer,"ISHOV, ALEXANDER",UNIVERSITY OF FLORIDA,FL,"$163,125"
Prostate Cancer,2017,NCI,1R21CA205094-01A1,,Primers: Combining Radiotherapy and Immunotherapy using next genertaion radiotherapy biomaterials,"NGWA, WILFRED",DANA-FARBER CANCER INST,MA,"$229,187"
Prostate Cancer,2017,NCI,1R21CA216052-01,,Prostate Cancer and Obesogenic Factors,"MACIAS, EVERARDO",CEDARS-SINAI MEDICAL CENTER,CA,"$203,914"
Prostate Cancer,2017,NCI,5R01CA137050-08,,Mechanism and treatment of PTEN mutant prostate tumorigenesis,"TROTMAN, LLOYD",COLD SPRING HARBOR LABORATORY,NY,"$398,400"
Prostate Cancer,2017,NCI,5R01CA200423-15,,Chemical Glycoproteomics,"BERTOZZI, CAROLYN",STANFORD UNIVERSITY,CA,"$349,310"
Prostate Cancer,2017,NCI,5R21CA192185-03,,Autophagy-mediated immune responses to oncolytic VSV,"HISCOTT, JOHN",ISTITUTO PASTEUR ITALIA FONDAZIONE CENCI BOLOGNETTI,ITALY,"$117,072"
Prostate Cancer,2017,NCI,7R21CA202404-02,,MicroRNAs Modulate Therapy Resistance in Prostate Cancer,"NADIMINTY, NAGALAKSHMI",UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS,OH,"$200,318"
Prostate Cancer,2017,NIBIB,5R01EB017449-05,,Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods,"VIGNERON, DANIEL","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$1,185,440"
Prostate Cancer,2017,NIEHS,5R01ES011126-14,,A NESTED CASE-CONTROL STUDY OF PROSTATE CARCINOGENESIS,"RYBICKI, BENJAMIN",HENRY FORD HEALTH SYSTEM,MI,"$473,334"
Prostate Cancer,2017,NCI,5R01CA178610-04,,The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer,"ALUMKAL, JOSHI",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$316,934"
Prostate Cancer,2017,NCI,5R01CA200660-02,,Targeting the MLL complex in Castration Resistant Prostate Cancer,"GREMBECKA, JOLANTA",UNIVERSITY OF MICHIGAN,MI,"$386,776"
Prostate Cancer,2017,NCI,5R01CA205001-02,,Histologic and Immunohistochemical Biomarkers for Heavily Treated Metastatic Prostate Cancer.,"HUANG, JIAOTI",DUKE UNIVERSITY,NC,"$271,066"
Prostate Cancer,2017,NCI,1R21CA206013-01A1,,(PQ1) Cellular senescence as an initiating event in malignant transformation,"DAVID, GREGORY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$203,400"
Prostate Cancer,2017,NCI,5R01CA196270-03,,Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer,"CHAKRAVARTI, DEBABRATA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$441,943"
Prostate Cancer,2017,NCI,5U01CA086402-17,,San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR),"LEACH, ROBIN",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$337,606"
Prostate Cancer,2017,NCI,5R21CA201865-02,,Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness,"LIANG, GANGNING",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$179,438"
Prostate Cancer,2017,NCI,5R21CA196434-02,,Supramolecular matrix materials for prostate cancer cell biology,"VANDER GRIEND, DONALD",UNIVERSITY OF CHICAGO,IL,"$197,500"
Prostate Cancer,2017,NCI,5R01CA184712-04,,Precision Medicine Approach to Prostate Cancer Active Surveillance,"MOSQUERA, JUAN",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$695,027"
Prostate Cancer,2017,NIGMS,5R01GM070335-18,,Bayesian Approaches to Model Selection for Survival Data,"IBRAHIM, JOSEPH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$383,181"
Prostate Cancer,2017,NCI,1R03CA216134-01,,PPP2R2A tumor suppression haploinsufficiency in prostate cancer,"GRANA, XAVIER",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$79,250"
Prostate Cancer,2017,NCI,1R01CA208758-01A1,,Targeted Payment Cuts to Reduce Unproven Care,"HOWARD, DAVID",EMORY UNIVERSITY,GA,"$336,912"
Prostate Cancer,2017,NCI,5R01CA182438-04,,Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer,"KIM, HYUNG",CEDARS-SINAI MEDICAL CENTER,CA,"$495,841"
Prostate Cancer,2017,NCI,5R01CA183962-03,,Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care,"HERNANDEZ-BOUSSARD, TINA",STANFORD UNIVERSITY,CA,"$731,415"
Prostate Cancer,2017,NCI,5R01CA196662-02,,Analysis of drug response in organoids and mouse models,"SHEN, MICHAEL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$597,601"
Prostate Cancer,2017,NCI,5R01CA204924-02,,Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy,"BLASBERG, RONALD",SLOAN-KETTERING INST CAN RESEARCH,NY,"$669,635"
Prostate Cancer,2017,NHGRI,5R01HG008126-02,,Prioritizing rare variants associated with cancer using non-coding annotation,"GERSTEIN, MARK",YALE UNIVERSITY,CT,"$785,220"
Prostate Cancer,2017,NCI,1R01CA208258-01A1,,Targeting a Novel Epigenetic Signaling Nexus ACK1-pY88H4-AR/AR-V7 in Drug Resistant Metastatic Prostate Cancer,"MAHAJAN, NUPAM",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$369,843"
Prostate Cancer,2017,NCI,1R01CA204121-01A1,,Molecular mechanisms specific to ETS transcription factors that drive oncogenesis,"HOLLENHORST, PETER",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$359,523"
Prostate Cancer,2017,NCI,5R01CA187342-04,,Role of extracellular Hsp90 in epithelial cell polarity and invasion,"ISAACS, JENNIFER",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$319,409"
Prostate Cancer,2017,NIGMS,1R01GM120221-01A1,,Novel genomic mechanism for ligand-dependent transcription by androgen receptor,"WANG, QIANBEN",OHIO STATE UNIVERSITY,OH,"$322,031"
Prostate Cancer,2017,NCI,1R56CA204315-01A1,,ARF1 signaling in prostate cancer,"WU, GUANGYU",AUGUSTA UNIVERSITY,GA,"$243,960"
Prostate Cancer,2017,NCI,5P01CA093900-13,5985,Administrative Core,"KELLER, EVAN",UNIVERSITY OF MICHIGAN,MI,"$334,899"
Prostate Cancer,2017,NCI,5P01CA093900-13,5988,Macrophages induce a tumor-promoting stable EMT in prostate cancer,"PIENTA, KENNETH",JOHNS HOPKINS UNIVERSITY,MD,"$375,848"
Prostate Cancer,2017,NCI,5P01CA093900-13,5989,Regulation of the PCa Metastatic Phenotype by the HSC Niche,"TAICHMAN, RUSSELL",UNIVERSITY OF MICHIGAN,MI,"$311,965"
Prostate Cancer,2017,NCI,5P01CA093900-13,5990,Tumor microvesicle-mediated modulation of the bone microenvironment,"KELLER, EVAN",UNIVERSITY OF MICHIGAN,MI,"$241,798"
Prostate Cancer,2017,NCI,5P01CA093900-13,5991,The role of bone marrow macrophages in skeletal metastasis,"MCCAULEY, LAURIE",UNIVERSITY OF MICHIGAN,MI,"$246,260"
Prostate Cancer,2017,NCI,5R01CA131945-09,,Molecular Link Between Metabolic Syndrome and Prostate Cancer,"LODA, MASSIMO",DANA-FARBER CANCER INST,MA,"$382,955"
Prostate Cancer,2017,NCI,5U01CA183031-03,,PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$393,306"
Prostate Cancer,2017,NCI,5R01CA196835-02,,Treatment of Castration-resistant Prostate Cancer (CRPC),"LIU, XIAOQI",PURDUE UNIVERSITY,IN,"$354,563"
Prostate Cancer,2017,NCI,5R21CA202417-02,,Gene-Gene Interactions and Their Functional Roles in Prostate Cancer Aggressiveness,"LIN, HUI-YI",LSU HEALTH SCIENCES CENTER,LA,"$135,829"
Prostate Cancer,2017,NCI,5F31CA200139-03,,Germline Genetic Pathways for Prostate Cancer Risk and Progression,"TAI, CAROLINE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$35,511"
Prostate Cancer,2017,NCI,5F30CA210329-02,,Development of a Multimodal Deep Learning Model for the Generation of Cancer Probability Maps and Imaging Biomarkers for Prostate Cancer using Multiparametric MRI,"SARMA, KARTHIK",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$37,542"
Prostate Cancer,2017,NCI,5R01CA161018-05,,Mechanism of PIN development in Abi1/Hssh3bp1 KO mouse,"KOTULA, LESZEK",UPSTATE MEDICAL UNIVERSITY,NY,"$378,420"
Prostate Cancer,2017,NCI,5R03CA202780-02,,"Sources and impact of stigma for rural breast, prostate and lung cancer survivors","THORBURN, SHERYL",OREGON STATE UNIVERSITY,OR,"$73,500"
Prostate Cancer,2017,NCI,5P50CA090381-15,5015,Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate Cance,"MUCCI, LORELEI",DANA-FARBER CANCER INST,MA,"$360,051"
Prostate Cancer,2017,NCI,5P50CA090381-15,5016,Gleason-based mRNA and Metabolomic Profiling to Predict Prostate Cancer Progress,"LODA, MASSIMO",DANA-FARBER CANCER INST,MA,"$266,838"
Prostate Cancer,2017,NCI,5P50CA090381-15,5017,Genomic Determinants of Resistance to Primary Androgen Deprivation Therapy and A,"GARRAWAY, LEVI",DANA-FARBER CANCER INST,MA,"$260,826"
Prostate Cancer,2017,NCI,5P50CA090381-15,5018,Targeting Mechanisms Driveing AR Activity in Advanced CRPC,"BALK, STEVEN",DANA-FARBER CANCER INST,MA,"$378,750"
Prostate Cancer,2017,NCI,5P50CA090381-15,5019,Administrative Core,"KANTOFF, PHILIP",DANA-FARBER CANCER INST,MA,"$284,486"
Prostate Cancer,2017,NCI,5P50CA090381-15,5020,Biostatistics and Computational Biology Core,"REGAN, MEREDITH",DANA-FARBER CANCER INST,MA,"$181,636"
Prostate Cancer,2017,NCI,5P50CA090381-15,5021,Tissue and Pathology Core,"LODA, MASSIMO",DANA-FARBER CANCER INST,MA,"$263,457"
Prostate Cancer,2017,NCI,5P50CA090381-15,5022,Developmental Research Program,"KANTOFF, PHILIP",DANA-FARBER CANCER INST,MA,"$151,978"
Prostate Cancer,2017,NCI,5P50CA090381-15,5023,Career Development Program,"KANTOFF, PHILIP",DANA-FARBER CANCER INST,MA,"$151,978"
Prostate Cancer,2017,NCI,1K99CA207730-01A1,,Evaluation of dynamic strategies of cancer care,"GARCIA DE ALBENIZ, XABIER",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$137,137"
Prostate Cancer,2017,NCI,5F30CA210379-02,,The Role of Centromeres in the Molecular Biology of Prostate Cancer,"SAHA, ANJAN",UNIVERSITY OF MICHIGAN,MI,"$39,067"
Prostate Cancer,2017,NCI,5R33CA196457-03,,Improving biospecimen quality by verifying adequacy at the point-of-acquisition with ex vivo structured illumination microscopy,"BROWN, JONATHAN",TULANE UNIVERSITY OF LOUISIANA,LA,"$302,416"
Prostate Cancer,2017,NCI,5F30CA200411-04,,Optimization of Non-Ablative Focused Ultrasound Therapy for Tumor Immunity,"SKALINA, KARIN","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$49,044"
Prostate Cancer,2017,NCI,5U01CA184966-03,,Genetic factors for race related prostate cancer.,"DAHIYA, RAJVIR",NORTHERN CALIFORNIA INSTITUTE/RES/EDU,CA,"$318,098"
Prostate Cancer,2017,NCI,5R42CA186414-04,,Intra-procedure Deformable Ultrasound-MRI Fusion for Prostate Biopsies,"PAPADEMETRIS, XENOPHON","ZMK MEDICAL TECHNOLOGIES, D/B/A  EIGEN",CA,"$491,366"
Prostate Cancer,2017,NIDDK,1R21DK110644-01A1,,Bomb Pulse Carbon-14 Dating of Prostate Tissues to Elucidate the Origins of BPH,"VANDER GRIEND, DONALD",UNIVERSITY OF CHICAGO,IL,"$284,771"
Prostate Cancer,2017,NCI,5P30CA016086-41,8624,Rapid Case Ascertainment,"OLSHAN, ANDREW",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$98,923"
Prostate Cancer,2017,NCI,5K07CA190541-03,,Repurposing Metformin and Aspirin for Prostate Cancer Prevention and Control,"TAN, XIANGLIN",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$170,541"
Prostate Cancer,2017,NCI,5R01CA175491-05,,Improving prostate cancer screening by integration of SNPs with blood biomarkers,"KLEIN, ROBERT",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$575,419"
Prostate Cancer,2017,NCI,5R01CA199668-03,,Stimuli-responsive crosslinked theranostics against advanced prostate cancer,"LI, YUANPEI",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$359,138"
Prostate Cancer,2017,NCI,5R01CA172436-04,,Biomarkers of Hormone Therapy Response in a Multicenter Prostate Cancer Trial,"GOLDKORN, AMIR",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$665,642"
Prostate Cancer,2017,NCI,5F32CA192630-03,,AR variant regulation during EMT and disease progression,"WARE, KATHRYN",DUKE UNIVERSITY,NC,"$60,990"
Prostate Cancer,2017,NCI,5R01CA207749-02,,Impact of Web-Based Lifestyle Interventions on Prostate Cancer Prognosis,"KENFIELD, STACEY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$672,441"
Prostate Cancer,2017,NCI,5F32CA203473-02,,The development of radiolabeled probes for imaging and therapy which target the chemokine CXCR4,"AMOR-COARASA, ALEJANDRO",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$59,166"
Prostate Cancer,2017,NIGMS,5R01GM027681-37,,Programmable DNA Binding Oligomers for Control of Transcription,"DERVAN, PETER",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$408,538"
Prostate Cancer,2017,NCI,5R01CA173200-06,,Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors,"KRAFT, ANDREW",UNIVERSITY OF ARIZONA,AZ,"$318,513"
Prostate Cancer,2017,NIDDK,5R03DK110497-02,,Interplay Between Stem Cells and Inflammation in Benign Prostatic Hyperplasia,"STRAND, DOUGLAS",UT SOUTHWESTERN MEDICAL CENTER,TX,"$81,000"
Prostate Cancer,2017,NCI,5R21CA206953-02,,Transforming fluorescence lifetime imaging microscopy into a fast and simple platform for high-content molecular analysis,"HAUN, JERED",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$260,846"
Prostate Cancer,2017,NCI,5R01CA207645-02,,A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use,"WEBER, WOLFGANG",SLOAN-KETTERING INST CAN RESEARCH,NY,"$558,907"
Prostate Cancer,2017,NCI,5K01CA188412-04,,PSMAs role in signal transduction pathway switching in prostate cancer,"CAROMILE, LESLIE",UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,CT,"$100,396"
Prostate Cancer,2017,NCI,5K22CA188169-03,,Clonal analysis of epithelial stem cells in prostate regeneration and cancer,"TALOS, FLAMINIA",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$219,686"
Prostate Cancer,2017,NCI,5R01CA189623-04,,"Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.","GEORGIOU, GEORGE","UNIVERSITY OF TEXAS, AUSTIN",TX,"$580,448"
Prostate Cancer,2017,NCI,5K07CA178258-05,,Optimal Strategy for Conservative Management of Prostate Cancer,"LOEB, STACY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$177,326"
Prostate Cancer,2017,NCCIH,5R01AT009152-03,,Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease,"KONG, AH-NG","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$666,025"
Prostate Cancer,2017,NCI,5R01CA190713-04,,cis-splicing of adjacent genes in prostate cancer,"LI, HUI",UNIVERSITY OF VIRGINIA,VA,"$327,850"
Prostate Cancer,2017,NCI,5U54CA199091-03,6530,Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer,"MIRKIN, CHAD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$628,901"
Prostate Cancer,2017,NCI,5R21CA202122-02,,Targeting the glucocorticoid receptor in enzalutamide resistant prostate cancer,"GARABEDIAN, MICHAEL",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$221,198"
Prostate Cancer,2017,NCI,5F32CA206277-02,,Innate Metabolic MRI of Macrophage Infiltration in Prostate Cancer,"LEFTIN, AVIGDOR",SLOAN-KETTERING INST CAN RESEARCH,NY,"$65,250"
Prostate Cancer,2017,NIMHD,5U54MD008621-05,7211,Collaborations and Partnership Core,"SAMUEL, RAYMOND",HAMPTON UNIVERSITY,VA,"$653,893"
Prostate Cancer,2017,NCI,5K08CA188615-04,,Resistance to Emerging Androgen Deprivation Therapies in Prostate Cancer,"VAN ALLEN, ELIEZER",DANA-FARBER CANCER INST,MA,"$177,120"
Prostate Cancer,2017,NCI,5R01CA191234-03,,Radiotherapy-induced tumor immunity,"SCHAUE, DORTHE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$352,275"
Prostate Cancer,2017,NCI,5P50CA180995-03,7210,Biostatistics and Bioinformatics Core,"JOVANOVIC, BORKO",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$230,430"
Prostate Cancer,2017,NCI,5P50CA180995-03,7211,Biospecimen Pathology Core,"KAUL, KAREN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$248,808"
Prostate Cancer,2017,NCI,5P50CA180995-03,7212,"Administrative, Leadership Development and Advocacy Core","CATALONA, WILLIAM",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$217,941"
Prostate Cancer,2017,NCI,5P50CA180995-03,7213,Impact of Germline Genetic Variants and Failure of Active Surveillance for Prostate Cancer,"CATALONA, WILLIAM",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$240,469"
Prostate Cancer,2017,NCI,5P50CA180995-03,7214,Glucocorticoid Receptor Transcriptional Activity and the Evolution of Enzalutamide-Resistant CRPC,"SZMULEWITZ, RUSSELL",UNIVERSITY OF CHICAGO,IL,"$457,836"
Prostate Cancer,2017,NCI,5P50CA180995-03,7215,EPHB4 Receptor Kinase as a Target in Prostate Cancer,"ABDULKADIR, SARKI",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$288,070"
Prostate Cancer,2017,NCI,5P50CA180995-03,7216,Targeting FOXA1-downstream pathways: a novel therapeutic strategy for castration-resistant prostate cancer,"YU, JINDAN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$293,764"
Prostate Cancer,2017,NCI,5P50CA180995-03,7217,Developmental Research Program,"CATALONA, WILLIAM",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$228,332"
Prostate Cancer,2017,NCI,5P50CA180995-03,7218,Career Development Program,"BERGAN, RAYMOND",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$87,428"
Prostate Cancer,2017,NCI,5R35CA197566-02,,Mechanisms governing metastatic dormancy and reactivation,"GIANCOTTI, FILIPPO",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$959,998"
Prostate Cancer,2017,NCI,2R01CA090764-16,,P13K/PTEN/Akt signaling and the genesis of cancer,"HAY, NISSIM",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$366,329"
Prostate Cancer,2017,NCI,5P01CA140043-08,5160,Core A - Administration and Biostatistics,"ALTIERI, DARIO",WISTAR INSTITUTE,PA,"$148,744"
Prostate Cancer,2017,NCI,5P01CA140043-08,5161,Core B - Mass Spectrometry,"SPEICHER, DAVID",WISTAR INSTITUTE,PA,"$173,966"
Prostate Cancer,2017,NCI,5P01CA140043-08,5162,Project 1 - Mitochondrial reprogramming in prostate cancer metastasis,"ALTIERI, DARIO",WISTAR INSTITUTE,PA,"$276,329"
Prostate Cancer,2017,NCI,5P01CA140043-08,5163,Project 2 - Intercellular communication in prostate cancer,"LANGUINO, LUCIA",THOMAS JEFFERSON UNIVERSITY,PA,"$274,533"
Prostate Cancer,2017,NCI,5P01CA140043-08,5164,Project 3 - Mitochondrial regulation of the immunosuppressive prostate cancer microenvironment,"GABRILOVICH, DMITRY",WISTAR INSTITUTE,PA,"$274,075"
Prostate Cancer,2017,NCI,5P01CA140043-08,5165,Program Integration and Management,"ALTIERI, DARIO",WISTAR INSTITUTE,PA,"$92,188"
Prostate Cancer,2017,NCI,5K07CA187546-03,,Risk Prediction for Development of Adverse Effects FOllowing Radiotherapy for Prostate Cancer,"KERNS, SARAH",UNIVERSITY OF ROCHESTER,NY,"$129,867"
Prostate Cancer,2017,NIGMS,5SC1CA187494-04,,"Emotion-Regulation, Inflammatory Processes, and Depression in Prostate Cancer Sur","HOYT, MICHAEL",HUNTER COLLEGE,NY,"$390,000"
Prostate Cancer,2017,NCI,5U54CA199075-03,6376,Multimodality Molecular Nanoimaging of Cancer,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$332,933"
Prostate Cancer,2017,NCI,5U54CA199075-03,6372,Clinical Translational Core,"FAN, ALICE",STANFORD UNIVERSITY,CA,"$202,367"
Prostate Cancer,2017,NIBIB,5R01EB022134-02,,"Image-guided, Transcatheter Peptide Receptor Radio Therapy for Prostate Cancer","TWEEDLE, MICHAEL",OHIO STATE UNIVERSITY,OH,"$584,236"
Prostate Cancer,2017,NCI,5R01CA200064-03,,Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology,"BACKMAN, VADIM",NORTHWESTERN UNIVERSITY,IL,"$633,774"
Prostate Cancer,2017,NCI,5R01CA182670-05,,Developing targeted therapy with prostate cancer specific nanomedicine,"HSIEH, JER-TSONG",UT SOUTHWESTERN MEDICAL CENTER,TX,"$314,920"
Prostate Cancer,2017,NCI,5R01CA189295-04,,MRI Imaging and Genetic Signatures to Manage Prostate Cancer Overdiagnosis,"POLLACK, ALAN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$727,699"
Prostate Cancer,2017,NIGMS,5SC1CA193758-04,,Targeted Nanotherapy for prostate cancer,"SINGH, RAJESH",MOREHOUSE SCHOOL OF MEDICINE,GA,"$353,750"
Prostate Cancer,2017,NCI,5R33CA196458-02,,Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology,"BHARGAVA, ROHIT",UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,IL,"$367,076"
Prostate Cancer,2017,NCI,1F32CA213615-01A1,,Light-sheet microscopy (LSM) for rapid wide-area imaging and pathology of bread-loafed prostate specimens,"GLASER, ADAM",UNIVERSITY OF WASHINGTON,WA,"$56,694"
Prostate Cancer,2017,NCI,5R00CA187664-05,,Characterization of Epigenetic Targets in Prostate Cancer,"ASANGANI, IRFAN",UNIVERSITY OF PENNSYLVANIA,PA,"$249,000"
Prostate Cancer,2017,NIAAA,5R01AA024770-02,,"A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.","FERRARI, PIETRO",INTERNATIONAL AGENCY FOR RES ON CANCER,FR,"$494,761"
Prostate Cancer,2017,NCI,5K01CA172478-05,,Brachytherapy in situ dose-painting administered via gold-nanoparticle eluters,"NGWA, WILFRED",DANA-FARBER CANCER INST,MA,"$177,120"
Prostate Cancer,2017,NCI,5R01CA196931-02,,The Genetic Basis of Aggressive Prostate Cancer: The Role of Rare Variation,"HAIMAN, CHRISTOPHER",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$553,487"
Prostate Cancer,2017,NCI,5R01CA188609-04,,An inevitable mechanism of resistance to androgen-directed therapy,"DONG, YAN",TULANE UNIVERSITY OF LOUISIANA,LA,"$312,288"
Prostate Cancer,2017,NCI,1R01CA211762-01A1,,Targeted MRI contrast agents for differential diagnosis of prostate cancer,"LU, ZHENG-RONG",CASE WESTERN RESERVE UNIVERSITY,OH,"$423,352"
Prostate Cancer,2017,NCI,1F30CA217109-01A1,,Defining tolerance mechanisms regulating self-specific T cells,"LEE, VICTORIA",UNIVERSITY OF CHICAGO,IL,"$49,044"
Prostate Cancer,2017,NCI,5R01CA134675-08,,High-Specificity Imaging Agents for Aggressive Prostate Cancer,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$468,164"
Prostate Cancer,2017,NCI,5P30CA093373-15,8704,Prostate Urothelial Cancer Program,"EVANS, CHRISTOPHER",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$43,902"
Prostate Cancer,2017,NCI,5P50CA058236-22,5601,PEG-Prom Mediated Theranostics for Prostate Cancer,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$235,449"
Prostate Cancer,2017,NCI,5P50CA058236-22,5602,Tissue-Specific Radiation Sensitization of Prostate Cancer by Aptamer-Targeted siRNA Knock-Down of DNA Repair Pattiway,"LUPOLD, SHAWN",JOHNS HOPKINS UNIVERSITY,MD,"$224,127"
Prostate Cancer,2017,NCI,5P50CA058236-22,5604,Discovery and Pre-Clinical Translation of Rational Epigenetic-Drug/Targeted-Drug Targeted-Drug Combinations,"NELSON, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$249,124"
Prostate Cancer,2017,NCI,5P50CA058236-22,5605,MSC Delivery of PSA Activated Pro-Aerolysin for Prostate Cancer,"ISAACS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$250,184"
Prostate Cancer,2017,NCI,5P50CA058236-22,5606,Developing Telomere Length Variation as a Prognostic Test for Prostate Cancer,"PLATZ, ELIZABETH",JOHNS HOPKINS UNIVERSITY,MD,"$238,957"
Prostate Cancer,2017,NCI,5P50CA058236-22,5607,Administrative Core,"NELSON, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$148,303"
Prostate Cancer,2017,NCI,5P50CA058236-22,5608,Biospecimen/Pathology Core,"EPSTEIN, JONATHAN",JOHNS HOPKINS UNIVERSITY,MD,"$172,264"
Prostate Cancer,2017,NCI,5P50CA058236-22,5609,Biostatistics/Bioinformatics Core,"TROCK, BRUCE",JOHNS HOPKINS UNIVERSITY,MD,"$150,742"
Prostate Cancer,2017,NCI,5P50CA058236-22,5610,Developmental Research Program,"NELSON, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$162,138"
Prostate Cancer,2017,NCI,5P50CA058236-22,5611,Career Development Program,"NELSON, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$162,138"
Prostate Cancer,2017,NCI,5R01CA193497-03,,The role of MnSOD allelic variations in prostate cancer etiology and outcome,"DIAMOND, ALAN",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$407,025"
Prostate Cancer,2017,NCI,1F32CA213795-01A1,,Targeting hyaluronan in the tumor microenvironment to improve DNA vaccine immunotherapy,"DUPERRET, ELIZABETH",WISTAR INSTITUTE,PA,"$56,694"
Prostate Cancer,2017,NCI,1R01CA211861-01A1,,The Germ Cell Gene TDRD1 As A Novel Prostate Cancer Biomarker,"HE, BIN",BAYLOR COLLEGE OF MEDICINE,TX,"$362,569"
Prostate Cancer,2017,NCI,1R01CA211150-01A1,,Multi-Site Development & Evaluation of a Quantitative 3D Hyperpolarized C-13 MRI Clinical Prostate Cancer Exam,"BANKSON, JAMES",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$657,613"
Prostate Cancer,2017,NCI,5P50CA186786-04,7441,A Precision Medicine Approach to Elucidate Mechanisms of Progression,"CHINNAIYAN, ARUL",UNIVERSITY OF MICHIGAN,MI,"$327,989"
Prostate Cancer,2017,NCI,5P50CA186786-04,7442,Mechanisms of Sensitivity and Resistance to the Kinase Inhibitor Cabozantinib in Castrate Resistant Prostate Cancer,"KELLER, EVAN",UNIVERSITY OF MICHIGAN,MI,"$249,533"
Prostate Cancer,2017,NCI,5P50CA186786-04,7443,Development of Novel BET Bromodomain Inhibitors for the Treatment of Advanced,"WANG, SHAOMENG",UNIVERSITY OF MICHIGAN,MI,"$260,745"
Prostate Cancer,2017,NCI,5P50CA186786-04,7444,Developing Schlap1 and Other IncRNAs as Prostate Cancer Biomarkers in Urine,"WEI, JOHN",UNIVERSITY OF MICHIGAN,MI,"$237,945"
Prostate Cancer,2017,NCI,5P50CA186786-04,7445,Administration,"CHINNAIYAN, ARUL",UNIVERSITY OF MICHIGAN,MI,"$277,387"
Prostate Cancer,2017,NCI,5P50CA186786-04,7446,Biostatistics,"TSODIKOV, ALEXANDER",UNIVERSITY OF MICHIGAN,MI,"$179,595"
Prostate Cancer,2017,NCI,5P50CA186786-04,7447,Tissue/Informatics,"KUNJU, LAKSHMI",UNIVERSITY OF MICHIGAN,MI,"$462,806"
Prostate Cancer,2017,NCI,5P50CA186786-04,7448,Developmental Research Program,"HUSSAIN, MAHA",UNIVERSITY OF MICHIGAN,MI,"$101,651"
Prostate Cancer,2017,NCI,5P50CA186786-04,7449,Career Development Program,"COONEY, KATHLEEN",UNIVERSITY OF MICHIGAN,MI,"$87,349"
Prostate Cancer,2017,NCI,5U54CA143924-09,6762,Functional Genetic variants as modifiers of prostate cancer progression in Native Americans,"WILDER, JASON",UNIVERSITY OF ARIZONA,AZ,"$107,189"
Prostate Cancer,2017,NCI,5R01CA193239-03,,Role of RUNX2 in prostate cancer intratumoral androgen synthesis and progression,"HUANG, HAOJIE",MAYO CLINIC ROCHESTER,MN,"$363,713"
Prostate Cancer,2017,NCI,5R01CA198145-02,,Improving Prostate Cancer Outcome Prediction Through Noninvasive exRNA Assessment,"COOPERBERG, MATTHEW","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$642,122"
Prostate Cancer,2017,NCI,5R01CA196634-02,,Improving chemotherapy of castration-resistant prostate cancer,"LIU, XIAOQI",PURDUE UNIVERSITY,IN,"$354,563"
Prostate Cancer,2017,NCI,5R01CA207118-02,,Role of histone demethylase JMJD1A in the DNA damage response of prostate cancer cells,"QI, JIANFEI",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$353,419"
Prostate Cancer,2017,NCI,5R01CA183570-05,,PROMISS - Prostate Modeling to Identify Surveillance Strategies,"ETZIONI, RUTH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$565,071"
Prostate Cancer,2017,NCI,5R01CA195732-02,,The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy,"LICHT, JONATHAN",UNIVERSITY OF FLORIDA,FL,"$348,844"
Prostate Cancer,2017,NCI,1R01CA208236-01A1,,MR Fingerprinting and Computerized Decision Support for Prostate Cancer,"GULANI, VIKAS",CASE WESTERN RESERVE UNIVERSITY,OH,"$554,035"
Prostate Cancer,2017,NCI,1R01CA217098-01,,High resolution volumetric MRI for prostate cancer active surveillance,"KIM, HYUNG",CEDARS-SINAI MEDICAL CENTER,CA,"$373,652"
Prostate Cancer,2017,NCI,5R01CA182503-04,,Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer,"CARVER, BRETT",SLOAN-KETTERING INST CAN RESEARCH,NY,"$439,351"
Prostate Cancer,2017,NCI,5R33CA183688-03,,RASL-Seq Expression Profiling of FFPE Tissues,"YEAKLEY, JOANNE","BIOSPYDER TECHNOLOGIES, INC.",CA,"$332,225"
Prostate Cancer,2017,NCI,5R01CA208254-02,,Analysis of Blood Borne Markers in Hormone Sensitive Metastatic Prostate Cancer,"SWEENEY, CHRISTOPHER",DANA-FARBER CANCER INST,MA,"$481,793"
Prostate Cancer,2017,NCI,5U01CA199338-03,,Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations,"ETZIONI, RUTH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$1,036,582"
Prostate Cancer,2017,NCI,5F30CA210912-02,,Cell-Mediated Immunity Following Listeria monocytogenes Induced Inflammasome Activation,"THEISEN, ERIN",UNIVERSITY OF WISCONSIN-MADISON,WI,"$44,044"
Prostate Cancer,2017,NCI,5R01CA178888-04,,MnTE-2-PyP as a radioprotector in prostate cancer therapy,"OBERLEY-DEEGAN, REBECCA",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$314,612"
Prostate Cancer,2017,NCI,5R01CA196259-03,,The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression,"DIGIOVANNI, JOHN","UNIVERSITY OF TEXAS, AUSTIN",TX,"$396,302"
Prostate Cancer,2017,RMAP,5U19CA179512-05,7165,Regulated Release and Paracrine Function of Ex-microRNAs in Prostate Cancer,"BLELLOCH, ROBERT","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$166,988"
Prostate Cancer,2017,NIGMS,5SC2CA211027-02,,Influence of Androgen Deprivation and Tumor Microenvironment on Epigenetic Silencing of Tumor Metastasis Suppressor KISS1 during Prostate Cancer Progression,"WANG, HONGHE",TUSKEGEE UNIVERSITY,AL,"$147,000"
Prostate Cancer,2017,NIGMS,5R01GM114080-03,,Echogenic Polymersomes for Triggered Contents Release,"MALLIK, SANKU",NORTH DAKOTA STATE UNIVERSITY,ND,"$287,625"
Prostate Cancer,2017,RMAP,5UH3TR000928-05,,Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni,"ABDEL-MAGEED, ASIM",TULANE UNIVERSITY OF LOUISIANA,LA,"$999,911"
Prostate Cancer,2017,NCI,5R01CA190105-04,,(PQC4) Habitats in Prostate Cancer,"GILLIES, ROBERT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$681,586"
Prostate Cancer,2017,NCI,5F30CA203446-02,,Contributions of sympathetic signals to prostate cancer progression.,"ZAHALKA, ALI","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$49,044"
Prostate Cancer,2017,NCI,5U01CA196390-03,,Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry,"PIENTA, KENNETH",JOHNS HOPKINS UNIVERSITY,MD,"$802,958"
Prostate Cancer,2017,NCI,5R01CA185457-04,,(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment,"FRANGIONI, JOHN","CURADEL, LLC",MA,"$640,378"
Prostate Cancer,2017,NCI,5R01CA206488-02,,"HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers","NIXON, DOUGLAS",GEORGE WASHINGTON UNIVERSITY,DC,"$508,654"
Prostate Cancer,2017,NCI,5P20CA192992-04,5264,Training and Education Program,"ODEDINA, FOLAKEMI",UNIVERSITY OF FLORIDA,FL,"$1,045"
Prostate Cancer,2017,NCI,5U24CA180918-05,,Quantitative Image Informatics for Cancer Research (QIICR),"KIKINIS, RON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$668,865"
Prostate Cancer,2017,NCI,5R01CA179115-04,,"Dynamic, multi-cohort prediction modeling of prostate biopsy outcome","VICKERS, ANDREW",SLOAN-KETTERING INST CAN RESEARCH,NY,"$442,771"
Prostate Cancer,2017,NCI,5P50CA097186-15,7589,Targeting SEMA3C in Castration Resistant Prostate Cancer,"GLEAVE, MARTIN",UNIVERSITY OF BRITISH COLUMBIA,CANADA,"$571,029"
Prostate Cancer,2017,NCI,5P50CA097186-15,7590,Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$219,667"
Prostate Cancer,2017,NCI,5P50CA097186-15,7591,Exploiting Mechanisms of Response and Resistance to Next Generation Androgen Pathway Antagonists,"MOSTAGHEL, ELAHE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$190,467"
Prostate Cancer,2017,NCI,5P50CA097186-15,7592,Leadership and Administration,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$356,933"
Prostate Cancer,2017,NCI,5P50CA097186-15,7594,Biostatistics,"ETZIONI, RUTH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$208,783"
Prostate Cancer,2017,NCI,5P50CA097186-15,7595,Clinical,"YU, EVAN",UNIVERSITY OF WASHINGTON,WA,"$265,853"
Prostate Cancer,2017,NCI,5P50CA097186-15,7596,Developmental Research Program,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$203,813"
Prostate Cancer,2017,NCI,5P50CA097186-15,7597,Career Development Program,"STANFORD, JANET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$203,812"
Prostate Cancer,2017,NCI,5U01CA184374-03,,Genetics of Prostate Cancer in Africa,"REBBECK, TIMOTHY",DANA-FARBER CANCER INST,MA,"$1,707,746"
Prostate Cancer,2017,NCI,5U01CA198900-03,,Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling,"TSENG, HSIAN-RONG",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$470,021"
Prostate Cancer,2017,NCI,5R01CA206100-02,,Automatic Pelvic Organ Delineation in Prostate Cancer Treatment,"SHEN, DINGGANG",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$347,700"
Prostate Cancer,2017,NCI,5R01CA207757-02,,Exploiting RB1 deficiency for the treatment of lethal neuroendocrine prostate cancer,"GOODRICH, DAVID",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$505,760"
Prostate Cancer,2017,NCI,5R01CA207311-02,,Role of GATA2 signaling network in Lethal Prostate Cancer,"DOMINGO-DOMENECH, JOSEP",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$478,637"
Prostate Cancer,2017,NCI,5F32CA206394-02,,Targeting SDF1/CXCR4 signaling to mobilize and kill circulating and disseminated prostate tumor cells,"VALKENBURG, KENNETH",JOHNS HOPKINS UNIVERSITY,MD,"$57,066"
Prostate Cancer,2017,NCI,5U54CA096300-15,6960,Full Project A: Multivariate Prediction of Prostate Cancer in Puerto Rican and,"PETTAWAY, CURTIS",UNIVERSITY OF PUERTO RICO,PR,"$210,027"
Prostate Cancer,2017,NCI,5R01CA122320-10,,Chemical markers of heterocyclic aromatic amines for human biomonitoring,"TURESKY, ROBERT",UNIVERSITY OF MINNESOTA,MN,"$422,733"
Prostate Cancer,2017,NCI,5UM1CA182883-05,,PCPT and SELECT cohorts: Core Infrastructure Support for Cancer Research,"TANGEN, CATHERINE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$908,559"
Prostate Cancer,2017,NCI,5U01CA179701-05,,Role of chemokine receptor in disparities associated with prostate cancer progres,"SINGH, SHAILESH",MOREHOUSE SCHOOL OF MEDICINE,GA,"$95,778"
Prostate Cancer,2017,NIGMS,5R01GM112524-05,,Regulation of the Class IA PI 3-kinase PIK3CB,"BACKER, JONATHAN","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$404,897"
Prostate Cancer,2017,NCI,5P50CA092131-15,5079,Career Development Program,"REITER, ROBERT",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$218,761"
Prostate Cancer,2017,NCI,5P50CA092131-15,5078,Developmental Research Program,"REITER, ROBERT",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$264,974"
Prostate Cancer,2017,NCI,5P50CA092131-15,5077,Imaging Core,"WU, ANNA",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$191,032"
Prostate Cancer,2017,NCI,5P50CA092131-15,5076,Biostatistics and Bioinformatics Core,"HORVATH, STEVE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$188,068"
Prostate Cancer,2017,NCI,5P50CA092131-15,5075,Pathology Core,"SAID, JONATHAN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$191,030"
Prostate Cancer,2017,NCI,5P50CA092131-15,5074,Administrative Core,"REITER, ROBERT",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$191,030"
Prostate Cancer,2017,NCI,5P50CA092131-15,5073,Low-Fat/Fish Oil Diet and prostate Cancer Outcomes in Human Cohorts and Mouse Mo,"ARONSON, WILLIAM",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$256,935"
Prostate Cancer,2017,NCI,5P50CA092131-15,5072,Evaluating a Novel Strategy to Target Trop2 in Prostate Cancer,"WITTE, OWEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$263,817"
Prostate Cancer,2017,NCI,5P50CA092131-15,5071,PI3K/AKT and MAPK Pathway Inhibition Therapies in Metastatic and Castration Resi,"WU, HONG",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$263,817"
Prostate Cancer,2017,NCI,5P50CA092131-15,5070,Translating N-Cadherin Targeted Therapy in Castrate Resistant Prostate Cancer,"REITER, ROBERT",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$270,536"
Prostate Cancer,2017,NCI,5U54CA193489-03,7772,Project 2 - Clinical translation,"GATENBY, ROBERT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$336,548"
Prostate Cancer,2017,NCI,5P20CA192973-04,5195,Pilot Project #2,"PONNAZHAGAN, SELVARANGAN",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$44,761"
Prostate Cancer,2017,NCI,5U01CA196387-03,,Stanford Molecular and Cellular Characterization Laboratory,"BROOKS, JAMES",STANFORD UNIVERSITY,CA,"$699,416"
Prostate Cancer,2017,NCI,1U54CA217297-01,8200,Project 1 High-order assembly of MegaTrans complexes for hormone-independent enhancer activation,"LIU, ZHIJIE",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$388,559"
Prostate Cancer,2017,NCI,1U54CA217297-01,8201,Project 2 Fine-scale nucleosome repositioning of enhancers for hormone-independent genomic function,"WANG, QIANBEN",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$513,076"
Prostate Cancer,2017,NCI,1U54CA217297-01,8202,Project 3 Topological mapping of chromatin architectures for hormone-independent gene transcription,"JIN, VICTOR",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$410,994"
Prostate Cancer,2017,NCI,1R01CA217329-01,,Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer,"KNUDSEN, KAREN",THOMAS JEFFERSON UNIVERSITY,PA,"$367,422"
Prostate Cancer,2017,NCI,5R01CA205058-02,,Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsy,"GILL, INDERBIR",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$514,292"
Prostate Cancer,2017,NHLBI,5F31HL134231-02,,Opposing Effects of HDL Metabolism on Prostate Cancer,"TRAUGHBER, CYNTHIA",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$37,637"
Prostate Cancer,2017,NCI,2R44CA199826-02A1,,Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer.,"LI, YAJUAN","MOLECULAR THERANOSTICS, LLC",OH,"$1,000,342"
Prostate Cancer,2017,NCI,2R44CA180745-02,,"Nonclinical development of Nervelight, an intra-operative peripheral nerve imaging agent","KAHL, STEPHEN","MANZANITA PHARMACEUTICALS, INC.",CA,"$1,220,153"
Prostate Cancer,2017,NCI,5P20CA192976-04,5182,Project 2: 2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership,"MISHRA, MANOJ",ALABAMA STATE UNIVERSITY,AL,"$44,672"
Prostate Cancer,2017,NCI,5R01CA197910-03,,Chronic inhibition of androgen receptor signaling leads to neuroendocrine prostate cancer by trans differentiation of stem/progenitor cells,"MULHOLLAND, DAVID",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$387,731"
Prostate Cancer,2017,NIBIB,5R01EB021362-02,,NIR Nerve-specific Fluorescent Imaging for Robotic-assisted Radical Prostatectomy,"GIBBS, SUMMER",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$562,893"
Prostate Cancer,2017,NCI,5K22CA207883-02,,Targeting Ribosomal Biogenesis in Prostate Cancer,"MACIAS, EVERARDO",CEDARS-SINAI MEDICAL CENTER,CA,"$189,681"
Prostate Cancer,2017,NCI,5U01CA214194-02,,Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer,"SEMMES, OLIVER",EASTERN VIRGINIA MEDICAL SCHOOL,VA,"$430,450"
Prostate Cancer,2017,NCI,5UH2CA213392-02,,Impact of aging on prostate cancer with TMPRSS2-ETS gene fusion,"LI, ZHE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$44,999"
Prostate Cancer,2017,NIA,5UH2CA213392-02,,Impact of aging on prostate cancer with TMPRSS2-ETS gene fusion,"LI, ZHE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$45,001"
Prostate Cancer,2017,NCI,5U01CA214170-02,,Discovery and qualification of transcriptomic biomarkers for the early detection of aggressive prostate cancer,"CHINNAIYAN, ARUL",UNIVERSITY OF MICHIGAN,MI,"$573,018"
Prostate Cancer,2017,NCI,5P20CA202925-02,7202,Pilot Project 1,"FREEDMAN, JENNIFER",DUKE UNIVERSITY,NC,"$117,799"
Prostate Cancer,2017,NCI,5U01CA202939-02,,"Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer","KANTOFF, PHILIP",SLOAN-KETTERING INST CAN RESEARCH,NY,"$458,934"
Prostate Cancer,2017,NCI,5R50CA211242-02,,Cellular mechanisms of androgen action and androgen-response gene EAF2 in prostate cancer,"PASCAL, LAURA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$114,950"
Prostate Cancer,2017,NCI,5P20CA202924-02,7155,Project 1: Interrogation of novel race-related alternatively spliced androgen receptor target genes in prostate cancer.,"ONYENWOKE, ROB",NORTH CAROLINA CENTRAL UNIVERSITY,NC,"$26,889"
Prostate Cancer,2017,NCI,5R01CA200979-02,,RADIOLABELED ANTIBODIES TARGETING LAT1 FOR IMAGING AND THERAPY OF PROSTATE CANCER,"LAPI, SUZANNE",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$336,263"
Prostate Cancer,2017,NCI,5R50CA211271-02,,Genomics and bioinformatics analysis to understand castration-resistant prostate cancer,"ZHAO, CHANGSHENG",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$140,380"
Prostate Cancer,2017,NCI,5F99CA212489-02,,System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs,"KIM , HUEN",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$41,724"
Prostate Cancer,2017,NCI,5F99CA212455-02,,Leveraging polyamine metabolic stress as a novel therapy for prostate cancer,"AFFRONTI, HAYLEY",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$29,518"
Prostate Cancer,2017,NCI,5U54CA163069-07,6964,Novel mechanisms of SKP2 and AR signaling on the suppression of prostate cancer,"CHEN, ZHENBANG",MEHARRY MEDICAL COLLEGE,TN,"$194,311"
Prostate Cancer,2017,NCI,5U54CA163072-08,6542,Novel mechanisms of SKP2 and AR signaling on the suppression of prostate cancer,"MATUSIK, ROBERT",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$99,997"
Prostate Cancer,2017,NCI,5F99CA212225-02,,The Role of USP22 in Prostate Cancer Development and Progression,"MCCANN, JENNIFER",THOMAS JEFFERSON UNIVERSITY,PA,"$44,044"
Prostate Cancer,2017,NCI,1P50CA211024-01A1,5259,Administrative Core,"RUBIN, MARK",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$215,374"
Prostate Cancer,2017,NCI,1P50CA211024-01A1,5260,Biospecimen Core,"MOSQUERA, JUAN",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$131,795"
Prostate Cancer,2017,NCI,1P50CA211024-01A1,5261,Computational/Biostatistical Core,"ELEMENTO, OLIVIER",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$219,358"
Prostate Cancer,2017,NCI,1P50CA211024-01A1,5262,Project 1: Non-Invasive Clinical Assay for Early Detection of Treatment Resistance in Patients with Metastatic Prostate Cancer,"BELTRAN, HIMISHA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$351,884"
Prostate Cancer,2017,NCI,1P50CA211024-01A1,5263,Project 2: Targeting N-Myc and EZH2-driven Castrate Resistant Prostate Cancer,"RICKMAN, DAVID",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$350,628"
Prostate Cancer,2017,NCI,1P50CA211024-01A1,5264,Project 3: Towards Understanding Prostate Cancer Heterogeneity,"RUBIN, MARK",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$371,556"
Prostate Cancer,2017,NCI,1P50CA211024-01A1,5265,Project 4: Targeting Genomic Instability in Distinct Subclasses of Prostate Cancer,"BARBIERI, CHRISTOPHER",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$351,526"
Prostate Cancer,2017,NCI,1P50CA211024-01A1,5266,Developmental Research Program (DRP),"GIANNAKAKOU, PARASKEVI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$93,249"
Prostate Cancer,2017,NCI,1P50CA211024-01A1,5267,Career Enhancement Program (CEP),"GUDAS, LORRAINE",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$99,629"
Prostate Cancer,2017,NCI,5U54CA118948-12,6723,Project 1: CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer,"WANG, LIZHONG",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$203,169"
Prostate Cancer,2017,NCI,5U54CA118948-12,6724,Project 2: Molecular Regulation of Kaiso in Prostate Cancer,"YATES, CLAYTON",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$129,359"
Prostate Cancer,2017,NIBIB,1P41EB024495-01,5624,Molecular Imaging Reagents for Prostate Cancer Theranostics,"BHUJWALLA, ZAVER",JOHNS HOPKINS UNIVERSITY,MD,"$240,117"
Prostate Cancer,2017,NCI,5U54CA118623-12,7188,Full Project 2-Yates and Grizzle,"YATES, CLAYTON",TUSKEGEE UNIVERSITY,AL,"$68,373"
Prostate Cancer,2017,NCI,5P50CA140388-07,8545,Administrative Core,"LOGOTHETIS, CHRISTOPHER",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$266,818"
Prostate Cancer,2017,NCI,5P50CA140388-07,8546,Biostatistics and Bioinformatics,"DO, KIM-ANH",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$247,498"
Prostate Cancer,2017,NCI,5P50CA140388-07,8547,Biospecimen and Pathology,"TRONCOSO, PATRICIA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$242,693"
Prostate Cancer,2017,NCI,5P50CA140388-07,8548,Developmental Research Program,"THOMPSON, TIMOTHY",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$155,727"
Prostate Cancer,2017,NCI,5P50CA140388-07,8549,Career Enhancement Program,"GALLICK, GARY",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$155,727"
Prostate Cancer,2017,NCI,5P50CA140388-07,8550,Integrating Ipilimumab Immunotherapy with Approved Treatment Strategies in CRPC,"ALLISON, JAMES",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$264,902"
Prostate Cancer,2017,NCI,5P50CA140388-07,8551,Targeting Tumor Microenvironment-Induced Therapy Resistance in Prostate Cancer Bone Metastasis,"LIN, SUE-HWA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$254,719"
Prostate Cancer,2017,NCI,5P50CA140388-07,8552,Targeting Androgen Receptor and PARP for Synthetic Lethality in CRPC,"THOMPSON, TIMOTHY",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$267,790"
Prostate Cancer,2017,NCI,5P50CA140388-07,8553,"Mitochondria, MicroRNA, and Metabolites in Predicting Aggressive Prostate Cancer","WU, XIFENG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$244,139"
Prostate Cancer,2017,NCI,5P01CA203628-02,7230,Project 1: Acid Ceramidase-S1P Metabolic Axis and Regulation of Tumor Resistance to Apoptosis,"VOELKEL-JOHNSON, CHRISTINA",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$122,181"
Prostate Cancer,2017,NCI,1R01CA218615-01,,Exploiting ferroportin for cancer imaging and therapy,"GRIMM, JAN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$604,800"
Prostate Cancer,2017,NCI,5P01CA163227-05,6435,Epigenetic Reprogramming of AR Function in CRPC,"BROWN, MYLES",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$338,039"
Prostate Cancer,2017,NCI,5P01CA163227-05,6436,Administrative/Clinical/Biostatistics Core,"BALK, STEVEN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$137,494"
Prostate Cancer,2017,NCI,5P01CA163227-05,6437,Facility Biospecimen and Xenograft Core,"VESSELLA, ROBERT",UNIVERSITY OF WASHINGTON,WA,"$296,605"
Prostate Cancer,2017,NCI,5P01CA163227-05,6438,Steroid Analytical Core,"PENNING, TREVOR",UNIVERSITY OF PENNSYLVANIA,PA,"$274,391"
Prostate Cancer,2017,NCI,5P01CA163227-05,6432,Steroid Metabolism in Castration-Resistant Prostate Cancer,"NELSON, PETER",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$316,667"
Prostate Cancer,2017,NCI,5P01CA163227-05,6433,Basis for Androgen Receptor Antagonist Resistance in CRPC,"BALK, STEVEN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$293,118"
Prostate Cancer,2017,NCI,5P01CA163227-05,6434,Development of Castration Resistance by Alternative AR Splicing,"PLYMATE, STEPHEN",UNIVERSITY OF WASHINGTON,WA,"$389,164"
Prostate Cancer,2017,NIA,1R01AG056410-01,,Effects of Androgen Deprivation Therapy on Preclinical Symptoms of Alzheimer's Disease,"PANIZZON, MATTHEW",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$654,820"
Prostate Cancer,2017,NCI,1K08CA218530-01,,Transcriptional Regulation of the Androgen Receptor in Prostate Cancer,"TAKEDA, DAVID",DANA-FARBER CANCER INST,MA,"$177,056"
Prostate Cancer,2017,NCI,1R01CA218254-01,,Role of p62 in metabolic reprograming of the tumor stroma in prostate cancer,"DIAZ MECO CONDE, MARIA",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$578,994"
Prostate Cancer,2017,NCI,1R01CA218657-01,,Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors,"ROSSER, B R SIMON",UNIVERSITY OF MINNESOTA,MN,"$620,222"
Prostate Cancer,2017,NCI,1R01CA219154-01,,Effective Anti-Tumor Vaccination - Targeting Checkpoint Regulation at the Time of T-cell Activation,"MCNEEL, DOUGLAS",UNIVERSITY OF WISCONSIN-MADISON,WI,"$349,988"
Prostate Cancer,2017,NCI,1R01CA218442-01,,Creation of in vivo active chemical probes for CAMKK2 to treat cancer,"DREWRY, DAVID",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$691,617"
Prostate Cancer,2017,NCI,1R01CA218356-01,,A blood test to identify prostate cancer patients at risk for visceral metastasis,"POSADAS, EDWIN",CEDARS-SINAI MEDICAL CENTER,CA,"$620,500"
Prostate Cancer,2017,NCI,5U54CA118638-12,7113,CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer,"LILLARD, JAMES",MOREHOUSE SCHOOL OF MEDICINE,GA,"$104,228"
Prostate Cancer,2017,NCI,1K99CA218731-01,,Defining the Essential Determinants of Prostate Cancer Differentiation States,"PARK, JUNG WOOK",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$128,790"
Prostate Cancer,2017,NCI,5P30CA015704-42,5444,Research Program:  Prostate Cancer,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$103,290"
Prostate Cancer,2017,NCI,1K99CA218885-01,,Overcome the lineage plasticity conferred targeted therapy resistance in advanced prostate cancer,"MU, PING",SLOAN-KETTERING INST CAN RESEARCH,NY,"$146,189"
Prostate Cancer,2017,NCI,1R01CA218547-01,,Focal Laser Ablation of Prostate Cancer using MR/US Fusion,"MARKS, LEONARD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$627,518"
Prostate Cancer,2017,NCI,1R01CA218526-01,,High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer,"DI VIZIO, DOLORES",CEDARS-SINAI MEDICAL CENTER,CA,"$462,518"
Prostate Cancer,2017,NCI,1R03CA219336-01,,Novel Combinatorial Therapeutic Approach for Prostate Cancer,"AFAQ, FARRUKH",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$74,250"
Prostate Cancer,2017,NCI,1R03CA212890-01A1,,Overcoming EMT-driven metastatic castration-resistant prostate cancer,"MUNIRATHINAM, GNANASEKAR",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$79,950"
Prostate Cancer,2017,NCI,1R03CA198696-01A1,,Alteration of the miR-let-7c:Lin28 ratio as a predictor of therapy resistance in Prostate Cancer,"NADIMINTY, NAGALAKSHMI",UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS,OH,"$76,750"
Prostate Cancer,2017,NCI,3U54CA096300-15S1,,UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2),"LOPEZ-BERESTEIN, GABRIEL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$72,364"
Prostate Cancer,2017,NCI,3P01CA098912-13S1,,Prostate Cancer Bone Metastasis Biology and Targeting,"CHUNG, LELAND",CEDARS-SINAI MEDICAL CENTER,CA,"$129,570"
Prostate Cancer,2017,NCI,3R01CA112226-08S1,,Transcription repression in prostate cancer,"LOGAN, SUSAN",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$80,838"
Prostate Cancer,2017,NCI,3R01CA176671-05S1,,Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET,"LEWIS, JASON",SLOAN-KETTERING INST CAN RESEARCH,NY,"$15,013"
Prostate Cancer,2017,NCI,3R01CA178431-04S1,,Function of the Stem Cell Transcription Factor Sox2 in Prostate Cancer,"VANDER GRIEND, DONALD",UNIVERSITY OF CHICAGO,IL,"$91,635"
Prostate Cancer,2017,NCI,3R01CA184208-03S1,,Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer,"FRIGO, DANIEL",UNIVERSITY OF HOUSTON,TX,"$54,358"
Prostate Cancer,2017,NCI,1R21CA219793-01,,Focal Therapy of Prostate Cancer using Non-Thermal Tumor Ablation with Focused Ultrasound,"SCHADE, GEORGE",UNIVERSITY OF WASHINGTON,WA,"$111,413"
Prostate Cancer,2017,NCI,1R01CA212097-01A1,,Cell free nucleic acid-based biomarkers in advanced prostate cancer,"WANG, LIANG",MEDICAL COLLEGE OF WISCONSIN,WI,"$663,505"
Prostate Cancer,2017,NCI,1R01CA211141-01A1,,Active surveillance and patient reported outcomes in a diverse population of prostate cancer patients,"GOMEZ, SCARLETT","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$664,142"
Prostate Cancer,2017,NCI,1R01CA211350-01A1,,Study the Mechanism of Retinoblastoma Protein Mediated Androgen Receptor Transcriptional Repression Activity on DNA Replication,"CAI, CHANGMENG",UNIVERSITY OF MASSACHUSETTS BOSTON,MA,"$348,844"
Prostate Cancer,2017,NCI,1R21CA220155-01,,Role of myosin IC in prostate cancer metastasis,"HOFMANN, WILMA",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$127,600"
Prostate Cancer,2017,NCI,2R01CA151395-05,,PET-determined prostate brachytherapy dosing using intraoperative image-guidance,"SONG, DANNY",JOHNS HOPKINS UNIVERSITY,MD,"$532,313"
Prostate Cancer,2017,NCI,1R01CA200853-01A1,,Role of oncogenic phosphorylated MED1 in aggressive prostate cancer,"WANG, QIANBEN",OHIO STATE UNIVERSITY,OH,"$380,994"
Prostate Cancer,2017,NIGMS,1R01GM121798-01A1,,Peptide-based conjugate for a water-insoluble drug treating advanced prostate cancer,"CHENG, KUN",UNIVERSITY OF MISSOURI KANSAS CITY,MO,"$311,456"
Prostate Cancer,2017,NCI,1R01CA212403-01A1,,Role and targeting of PRMT5 in prostate cancer,"HU, CHANG-DENG",PURDUE UNIVERSITY,IN,"$547,569"
Prostate Cancer,2017,NCI,1R01CA208100-01A1,,Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance,"CHEN, YU",SLOAN-KETTERING INST CAN RESEARCH,NY,"$498,613"
Prostate Cancer,2017,NCI,1K01CA211965-01A1,,Constructing a Relational Bridge to Achieve High-Quality Prostate Cancer Care for African Americans,"PALMER, NYNIKKA","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$184,680"
Prostate Cancer,2017,NCI,2R01CA142824-06A1,,Image guided targeted biopsy of clinically significant prostate cancer with acoustic radiation force,"NIGHTINGALE, KATHRYN",DUKE UNIVERSITY,NC,"$546,174"
Prostate Cancer,2017,NIMHD,1R01MD012767-01,,Molecular Determinants of Social Factors in Prostate Cancer,"KUMAR, DEEPAK",NORTH CAROLINA CENTRAL UNIVERSITY,NC,"$649,342"
Prostate Cancer,2017,NCI,1R21CA198389-01A1,,Noninvasive Detection of Prostate Cancer with a Label-Free Imaging System,"YE, JING YONG",UNIVERSITY OF TEXAS SAN ANTONIO,TX,"$198,406"
Prostate Cancer,2017,NCI,1R01CA220314-01,,Race-related alternative splicing: novel targets in prostate cancer,"PATIERNO, STEVEN",DUKE UNIVERSITY,NC,"$361,013"
Prostate Cancer,2017,NCI,4R00CA197315-04,,Nuclear Factor I/B Action in Castrate Resistant Prostate Cancer,"GRABOWSKA, MAGDALENA",CASE WESTERN RESERVE UNIVERSITY,OH,"$249,000"
Prostate Cancer,2017,NCI,1R01CA215694-01A1,,Targeting Neuroendocrine Prostate Cancer Using Multi-Probe Hyperpolarized 13C MRI for Improved Treatment and Therapeutic Monitoring,"KURHANEWICZ, JOHN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$650,042"
Prostate Cancer,2017,NCI,3R01CA190289-03S1,,Compensatory steroidogenesis mechanisms in castration-resistant prostate cancer,"SHARIFI, NIMA",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$74,371"
Prostate Cancer,2017,NCI,1R21CA205096-01A1,,Treating prostate cancer by pharmacological coinhibition of the Warburg effect and lipogenesis,"FLAVENY, COLIN",SAINT LOUIS UNIVERSITY,MO,"$197,708"
Prostate Cancer,2017,NCI,3R01CA197996-02S1,,Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.,"SMIRAGLIA, DOMINIC",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$54,877"
Prostate Cancer,2017,NCI,3U01CA185490-04S1,,Molecular determinant of racial disparity in prostate cancer,"SINGH, AJAY",UNIVERSITY OF SOUTH ALABAMA,AL,"$41,253"
Prostate Cancer,2017,NCI,2R01CA130908-08A1,,Role of proinflammatory cytokine-induced AR degradation in castration-resistant prostate cancer,"HUANG, HAOJIE",MAYO CLINIC ROCHESTER,MN,"$377,625"
Prostate Cancer,2017,NCI,7R01CA154835-06,,Role of alpha6 beta1 Integrin in Prostate Cancer,"MIRANTI, CYNTHIA",UNIVERSITY OF ARIZONA,AZ,"$347,376"
Prostate Cancer,2017,NCI,1F32CA220988-01,,Identification of AR-variant nuclear import pathways in prostate cancer and elucidation of the molecular mechanisms underlying clinical taxane resistance,"MUKHTAR, EIMAN",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$58,620"
Prostate Cancer,2017,NINR,1R01NR016990-01A1,,"Efficacy of a Couple-focused, Tailored, Symptom Self-Management mHealth Intervention for Prostate Cancer Patients and Partners","SONG, LIXIN",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$544,248"
Prostate Cancer,2017,NCI,2R01CA154916-06,,Deciphering the role of the translational oncogenic program in Prostate Cancer,"RUGGERO, DAVIDE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$419,077"
Prostate Cancer,2017,NCI,1R41CA217491-01A1,,Small-molecule therapy for metastatic prostate cancer,"WU, DAQING","METCURE THERAPEUTICS, LLC",GA,"$224,999"
Prostate Cancer,2017,NCI,1R43CA221580-01,,Development of novel gallium-68 bisphosphonate for imaging bone metastases in prostate cancer,"ALEXOFF, DAVID","FIVE ELEVEN PHARMA, INC.",PA,"$225,000"
Prostate Cancer,2017,OD,3UM1CA182883-05S1,,Enhancing the PCPT/SELECT cohorts Core Infrastructure Grant to support studies evaluating dietary supplement use and disease risk,"TANGEN, CATHERINE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$161,281"
Prostate Cancer,2017,NCI,1P20CA221696-01,5552,Pilot 2: Watchful Living: A lifestyle intervention for black prostate cancer patients on active surveillance and their partners,"DIEP YEUNG, CASSANDRA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$43,618"
Prostate Cancer,2017,NCI,1P20CA221697-01,5556,Pilot Project 2: Watchful Living: A lifestyle intervention for black prostrate cancer patients on active surveillance and their partners,"SIMPSON, RICHARD",UNIVERSITY OF HOUSTON,TX,"$1,931"
Prostate Cancer,2017,NCI,1U54CA210962-01A1,5885,Project: Survivorship Care Physical Activity Initiative to Improve Disparities in HRQoL for Prostate Cancer Survivors (RELate Study),"TURNER, DAVID",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$170,370"
Prostate Cancer,2017,NCI,1U54CA210962-01A1,5886,A Phase 1b Trial of Oligomeric Procyanidin Complex in Combination with Metformin for Reduced AGE Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy,"LILLY, MICHAEL",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$74,450"
Prostate Cancer,2017,NCI,1U54CA210962-01A1,5887,Lifestyle Associated Metabolites Drive Neuroendocrine Differentiation in Prostate Cancer,"FINDLAY, VICTORIA",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$74,451"
Prostate Cancer,2017,NCI,1U54CA210963-01A1,5919,Project: Survivorship Care Physical Activity Initiative to Improve Disparities in HRQoL for Prostate Cancer Survivors (RELate Study),"AHMED, MAHTABBUDIN",SOUTH CAROLINA STATE UNIVERSITY,SC,"$124,472"
Prostate Cancer,2017,NCI,1U54CA210963-01A1,5920,A Phase 1b Trial of Oligomeric Procyanidin Complex in Combination with Metformin for Reduced AGE Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy,"BROWN, SHANORA",SOUTH CAROLINA STATE UNIVERSITY,SC,"$64,740"
Prostate Cancer,2017,NCI,1U54CA210963-01A1,5921,Lifestyle Associated Metabolites Drive Neuroendocrine Differentiation in Prostate Cancer,"KNOWELL, ASHLEY",SOUTH CAROLINA STATE UNIVERSITY,SC,"$62,112"
Prostate Cancer,2017,NIA,1R21AG057383-01,,Behavioral Economics Applications to Geriatrics Leveraging EHRs (BEAGLE),"PERSELL, STEPHEN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$234,715"
Prostate Cancer,2017,NCI,1R50CA221836-01,,Advanced statistical modeling and analytics for prostate cancer interventions,"GULATI, ROMAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$202,176"
Prostate Cancer,2017,NCI,261200800001E-111-0-34,,GWAS Studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$4,224,312"
Prostate Cancer,2017,NCI,261200800001E-111-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$1,380,084"
Prostate Cancer,2017,NCI,261201600007I-1-26100001-1,,"IGF::OT::IGF HHSN261201600007I/HHSN26100001, POP 03/01/2016 - 02/28/2017, PRIMARY PRODUCT/SERVICE CODE TO:  B537, DESCRIPTION: CENTRAL DATA COLLECTION CENTER (CDCC), WESTAT","MATHEW, SUNITHA","WESTAT, INC.",MD,"$1,045,358"
Prostate Cancer,2017,NCI,1F99CA223063-01,,Role of the tumor microenvironment in promoting drug resistance in castration resistant prostate cancer,"ZHANG, ZEDA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$45,544"
Prostate Cancer,2017,NCATS,3R43TR001283-02S1,,Development and Validation of a Novel Biomarker Assay for Cancer Diagnostics,"SELANDER, KATRI","BLONDIN BIOSCIENCE, LLC",AL,"$49,950"
Prostate Cancer,2017,NCI,3F32CA206394-01S1,,Targeting SDF1/CXCR4 signaling to mobilize and kill circulating and disseminated prostate tumor cells,"VALKENBURG, KENNETH",JOHNS HOPKINS UNIVERSITY,MD,"$1,040"
Prostate Cancer,2017,NCI,1U54CA224079-01,8717,Administative Core,"SAWYERS, CHARLES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$175,152"
Prostate Cancer,2017,NCI,1U54CA224079-01,8718,Project 1: Resistance caused by AR pathway reactivation,"SAWYERS, CHARLES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$935,583"
Prostate Cancer,2017,NCI,1U54CA224079-01,8719,Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy,"CHEN, YU",SLOAN-KETTERING INST CAN RESEARCH,NY,"$433,322"
Prostate Cancer,2017,NCI,1U54CA224079-01,8720,Project 3: Defining the appropriate context for targeting kinase signaling in combination with androgen receptor blockade to enhance therapeutic response in metastatic prostate cancer,"CARVER, BRETT",SLOAN-KETTERING INST CAN RESEARCH,NY,"$1,041,837"
Prostate Cancer,2017,NIMHD,5G12MD007590-30,8829,Recruitment/Hiring Faculty/Research Staff,"KHAN, SHAFIQ",CLARK ATLANTA UNIVERSITY,GA,"$115,032"
Prostate Cancer,2017,NIMHD,2U54MD007586-31,5295,Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer,"CHEN, ZHENBANG",MEHARRY MEDICAL COLLEGE,TN,"$307,062"
Prostate Cancer,2017,NCI,5U54MD010706-02,6590,Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors,"DRAKE, RICHARD",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$63,382"
Prostate Cancer,2017,NIMHD,5U54MD010706-02,6590,Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors,"DRAKE, RICHARD",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$189,248"
Prostate Cancer,2017,NCI,5U54MD010706-02,6591,Integrating Genomic and Sociobiological Data to Inform the Development of Prostate Cancer Treatment,"GATTONI-CELLI, SEBASTIANO",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$59,880"
Prostate Cancer,2017,NIMHD,5U54MD010706-02,6591,Integrating Genomic and Sociobiological Data to Inform the Development of Prostate Cancer Treatment,"GATTONI-CELLI, SEBASTIANO",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$178,792"
Prostate Cancer,2017,NCI,3R33CA196458-02S1,,Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology,"BHARGAVA, ROHIT",UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,IL,"$66,508"
Prostate Cancer,2017,NCI,3F32CA196080-01A1S1,,Investigating the role of autophagy in Tak1 null prostate cancer and TRAIL sensitivity,"GOODALL, MEGAN",UNIVERSITY OF COLORADO DENVER,CO,$316
Prostate Cancer,2017,NCI,7R21CA205627-02,,Novel Mouse Models to define Genetic Drivers of Aggressive Prostate Cancer,"ELLIS, LEIGH",DANA-FARBER CANCER INST,MA,"$171,281"
Prostate Cancer,2017,NCI,1R43CA224732-01,,Novel Single Chain Antibodies against MIF for Prostate Cancer Therapy,"LAI, NORMAN","IBEX BIOSCIENCES, LLC",MD,"$299,999"
Prostate Cancer,2017,NCI,1R41CA224646-01,,Drug-eluting Brachytherapy Implants for Chemo-radiation Therapy,"KUMAR, RAJIV","THERANANO, LLC",MA,"$225,000"
Prostate Cancer,2017,NIMHD,1R21MD012465-01,,"Disparities in care of prostate cancer survivors, a population-based cohort study","CHEN, RONALD",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$235,541"
Prostate Cancer,2017,NIBIB,4R00EB017729-03,,Transrectal Ultrasound and Photoacoustic Imagining of Prostate and Molecular Imag,"KOTHAPALLI, SRI",PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,PA,"$246,708"
Prostate Cancer,2017,NCI,3P01CA098912-13S2,,Prostate Cancer Bone Metastasis Biology and Targeting,"CHUNG, LELAND",CEDARS-SINAI MEDICAL CENTER,CA,"$116,372"
Prostate Cancer,2017,NCI,3U01CA196387-02S1,,Stanford Molecular and Cellular Characterization Laboratory,"BROOKS, JAMES",STANFORD UNIVERSITY,CA,"$78,500"
Prostate Cancer,2017,FIC,3R21CA202199-02S1,,Prostate Specific Membrane Antigen Targeted Photoacoustic Imaging for Prostate Cancer,"RAY, SANGEETA",JOHNS HOPKINS UNIVERSITY,MD,"$2,591"
Prostate Cancer,2017,NIDCR,3R21CA202199-02S1,,Prostate Specific Membrane Antigen Targeted Photoacoustic Imaging for Prostate Cancer,"RAY, SANGEETA",JOHNS HOPKINS UNIVERSITY,MD,"$14,810"
Prostate Cancer,2017,NIDDK,3R21CA202199-02S1,,Prostate Specific Membrane Antigen Targeted Photoacoustic Imaging for Prostate Cancer,"RAY, SANGEETA",JOHNS HOPKINS UNIVERSITY,MD,"$9,897"
Prostate Cancer,2017,NIEHS,3R21CA202199-02S1,,Prostate Specific Membrane Antigen Targeted Photoacoustic Imaging for Prostate Cancer,"RAY, SANGEETA",JOHNS HOPKINS UNIVERSITY,MD,"$21,796"
Prostate Cancer,2017,NLM,3R21CA202199-02S1,,Prostate Specific Membrane Antigen Targeted Photoacoustic Imaging for Prostate Cancer,"RAY, SANGEETA",JOHNS HOPKINS UNIVERSITY,MD,"$2,906"
Prostate Cancer,2017,NCI,3U24CA180918-05S1,,Quantitative Image Informatics for Cancer Research (QIICR),"KIKINIS, RON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$254,713"
Prostate Cancer,2017,NIGMS,7R01GM114306-04,,"Histone Lysine deMethylation: Structures, Inhibitions and Mechanisms","CHENG, XIAODONG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$310,370"
Prostate Cancer,2017,NCI,5R01CA169363-05,,Modulation of antitumor immunity by dietary soy and its isoflavone constituents,"CLINTON, STEVEN",OHIO STATE UNIVERSITY,OH,$1
Prostate Cancer,2017,NIGMS,7SC2CA200520-04,,Novel Hyperpolarized Agents for the Metabolic Imaging of Cancer,"BILLINGSLEY, KELVIN",CALIFORNIA STATE UNIVERSITY FULLERTON,CA,"$140,000"
Prostate Cancer,2017,NCI,261201300008I-2-26100010-1,,SUPPORT SERVICES FOR THE PLCO ETIOLOGIC & EARLY MARKER STUDIES(PLCO EEMS),"RILEY, TOM","INFORMATION MANAGEMENT SERVICES, INC.",MD,"$894,589"
Prostate Cancer,2017,NCI,1ZIACP010121-22,,Molecular Epidemiology Studies of Occupational and Environmental Exposures,"MOORE, LEE",NIH,,"$930,062"
Prostate Cancer,2017,NCI,1ZIACP010152-18,,PLCO Trial Etiologic and Early Marker Study,"HOOVER, ROBERT",NIH,,"$736,077"
Prostate Cancer,2017,NCI,1ZIACP010169-16,,"Nutrition, Metabolism, and Cancer","ZIEGLER, REGINA",NIH,,"$356,089"
Prostate Cancer,2017,NCI,1ZIACP010180-16,,Prostate Cancer Studies,"COOK, MICHAEL",NIH,,"$890,062"
Prostate Cancer,2017,NCI,1ZIACP010183-15,,Descriptive Studies and Record Linkage,"ANDERSON, WILLIAM",NIH,,"$725,750"
Prostate Cancer,2017,NCI,1ZIACP010184-15,,Consultation and Collaboration,"GRAUBARD, BARRY",NIH,,"$910,442"
Prostate Cancer,2017,NCI,1ZIACP010187-13,,Cancer Genetic Markers of Susceptibility,"HOOVER, ROBERT",NIH,,"$106,767"
Prostate Cancer,2017,NCI,1ZIACP010195-11,,"Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study","ABNET, CHRISTIAN",NIH,,"$2,038,418"
Prostate Cancer,2017,NCI,1ZIACP010207-08,,PLCO EEMS and Extended Follow Up,"HOOVER, ROBERT",NIH,,"$800,895"
Prostate Cancer,2017,NCI,1ZIACP010221-07,,Etiologic Studies of Prostate Cancer,"ALBANES, DEMETRIUS",NIH,,"$439,110"
Prostate Cancer,2017,NIEHS,1ZIAES103308-03,,Application of Statistical Methods in Epidemiology Studies,"ZHAO, SHANSHAN",NIH,,"$66,868"
Prostate Cancer,2017,NIEHS,1ZICES102545-10,,DNA Sequencing,"ARCHER, TREVOR",NIH,,"$1,865,206"
Prostate Cancer,2017,NCI,3U01CA196387-03S1,,Stanford Molecular and Cellular Characterization Laboratory,"BROOKS, JAMES",STANFORD UNIVERSITY,CA,"$314,000"
Prostate Cancer,2017,RMAP,1ZIATR000243-03,,Targeting Tumor-derived exRNA-Containing microvesicles by high throughput screening,"FERRER-ALEGRE, MARC",NIH,,"$180,000"
Prostate Cancer,2017,NICHD,1ZIAHD008751-16,,"Molecular Biology, Regulation, And Biochemistry of UDP-glucuronosyltransferases.","OWENS, IDA",NIH,,"$210,136"
Prostate Cancer,2017,NLM,1ZIALM010008-02,,Clinical and Informatics Research on Large Clinical Databases,"BAIK, SEO",NIH,,"$245,949"
Prostate Cancer,2017,NCI,ACN15006001-1-0-1,,NCI Early Detection Research Network:  Biomarker Reference and Resource Center (BRRC),NO PI IDENTIFIED,NIH,,"$800,000"
Prostate Cancer,2017,NCI,1ZIABC010425-18,,Strategies for Cancer Immunotherapy Clinical Trials,"SCHLOM, JEFFREY",NIH,,"$1,107,978"
Prostate Cancer,2017,NCI,1ZIABC010453-16,,Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,"FIGG, WILLIAM",NIH,,"$546,985"
Prostate Cancer,2017,NCI,1ZIABC010477-15,,Overhauser Enhanced Magnetic Resonance Imaging (OMRI),"CHERUKURI, MURALI",NIH,,"$1,036,044"
Prostate Cancer,2017,NCI,1ZIABC010499-15,,Maryland Prostate Cancer Case-Control Study,"AMBS, STEFAN",NIH,,"$723,107"
Prostate Cancer,2017,NCI,1ZIABC010547-15,,Development of Drugs That Target Prostate Cancer,"FIGG, WILLIAM",NIH,,"$410,239"
Prostate Cancer,2017,NCI,1ZIABC010607-14,,Ras-mediated signals in human epithelial cell transformation and metastasis,"SIEBENLIST, KATHLEEN",NIH,,"$316,298"
Prostate Cancer,2017,NCI,1ZIABC010624-14,,The Molecular Profile of Prostate Tumors in African-American Men,"AMBS, STEFAN",NIH,,"$271,166"
Prostate Cancer,2017,NCI,1ZIABC010655-13,,Prostate Cancer Imaging,"CHOYKE, PETER",NIH,,"$3,058,044"
Prostate Cancer,2017,NCI,1ZIABC010666-13,,Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"GULLEY, JAMES",NIH,,"$633,201"
Prostate Cancer,2017,NCI,1ZIABC010802-11,,Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,"SIEBENLIST, KATHLEEN",NIH,,"$632,597"
Prostate Cancer,2017,NCI,1ZIABC010834-11,,Intratumor heterogeneity and tumor evolution,"RIED, KARL",NIH,,"$1,004,995"
Prostate Cancer,2017,NCI,1ZIABC010886-10,,Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,"AMBS, STEFAN",NIH,,"$90,389"
Prostate Cancer,2017,NCI,1ZIABC010945-10,,Clinical trials employing cancer vaccine combination therapies,"GULLEY, JAMES",NIH,,"$633,201"
Prostate Cancer,2017,NCI,1ZIABC011053-10,,TMPRSS2-ERG chromosomal translocations and prostate cancer,"SIEBENLIST, KATHLEEN",NIH,,"$210,866"
Prostate Cancer,2017,NCI,1ZIABC011055-10,,Serum Antibody Profiling with a Carbohydrate Microarray,"GILDERSLEEVE, JEFFREY",NIH,,"$485,145"
Prostate Cancer,2017,NCI,1ZIABC011081-10,,Prostate Section,"PINTO, PETER",NIH,,"$443,471"
Prostate Cancer,2017,NCI,1ZIABC011124-10,,Oncogenic Met Signaling in Urologic Malignancies,"BOTTARO, DONALD",NIH,,"$496,098"
Prostate Cancer,2017,NCI,1ZIABC011307-08,,Self-assembling protoviral nanoparticles,"TARASOVA, NADYA",NIH,,"$369,655"
Prostate Cancer,2017,NCI,1ZIABC011406-07,,miRNA profiling  of prostate cancer in young and older male patients,"MERINO NEUMANN, MARIA",NIH,,"$89,159"
Prostate Cancer,2017,NCI,1ZIABC011552-04,,Targeting mechanisms of radiation resistance,"CITRIN, DEBORAH",NIH,,"$656,225"
Prostate Cancer,2017,NCI,1ZIABC011679-02,,Mechanisms driving evolution of aggressive prostate cancer,"SOWALSKY, ADAM",NIH,,"$581,343"
Prostate Cancer,2017,NCI,1ZIABC011680-02,,Early detection of prostate cancer using circulating tumor DNA,"SOWALSKY, ADAM",NIH,,"$581,343"
Prostate Cancer,2017,NCI,1ZIABC011713-02,,Mechanisms of resistance to Androgen Receptor inhibition in prostate cancer,"VANDERWEELE, DAVID",NIH,,"$645,742"
Prostate Cancer,2017,NCI,1ZIABC011719-02,,Multiregion sequencing of localized prostate cancer,"VANDERWEELE, DAVID",NIH,,"$129,149"
Prostate Cancer,2017,NCI,1ZIABC011770-01,,Evolution of prostate cancer genome,"VANDERWEELE, DAVID",NIH,,"$43,050"
Prostate Cancer,2017,NCI,1ZIABC011771-01,,Development of therapy for aggressive variant prostate cancer,"VANDERWEELE, DAVID",NIH,,"$43,050"
Prostate Cancer,2017,NCI,1ZIABC011782-01,,Mechanisms of pathogenesis in patient derived organoid models of prostate cancer,"SIEBENLIST, KATHLEEN",NIH,,"$738,029"
Prostate Cancer,2017,NCI,1ZIASC006538-24,,Development of Angiogenesis Inhibitors,"FIGG, WILLIAM",NIH,,"$410,239"
Prostate Cancer,2017,NCI,1ZIASC010098-15,,The Evaluation of Novel Therapeutics for Genitourinary Malignancies,"DAHUT, WILLIAM",NIH,,"$871,023"
Prostate Cancer,2017,NCI,1ZICBC010947-10,,Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility,"SIEBENLIST, KATHLEEN",NIH,,"$295,087"
Prostate Cancer,2017,NCI,1ZICBC010953-10,,Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"SIMPSON, ROBERT",NIH,,"$866,362"
Prostate Cancer,2017,NCI,1ZICBC011044-10,,Tissue Processing-Sequencing Facility,"VOCKE, CATHY",NIH,,"$906,825"
Prostate Cancer,2017,NCI,1ZICBC011047-10,,Animal Model and Genotyping Core Support Facility,"MERLINO, GLENN",NIH,,"$1,133,495"
Prostate Cancer,2017,NCI,1ZICSC006743-24,,Signal Transduction Events and the Regulation of Cell Growth,"NECKERS, JANE",NIH,,"$848,376"
Prostate Cancer,2017,NCI,1ZIDBC011089-10,,Clinical Nursing and Data Management Core,"LINEHAN, WILLIAM",NIH,,"$1,067,221"
Prostate Cancer,2017,NIMHD,3G12MD007599-30S2,,Basic and Translational Research Center for Reducing Health Disparities,"ANGULO, JESUS",HUNTER COLLEGE,NY,"$471,977"
Prostate Cancer,2017,NCI,3U01CA196390-03S1,,Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry,"PIENTA, KENNETH",JOHNS HOPKINS UNIVERSITY,MD,"$327,000"
Prostate Cancer,2017,NHGRI,1ZIAHG200331-13,,Genetic Epidemiology of Cancer,"BAILEY-WILSON, JOAN",NIH,,"$780,567"
Prostate Cancer,2017,NHGRI,1ZICHG200345-10,,NHGRI/DIR Bioinformatics and Scientific Programming Core,"BAXEVANIS, ANDREAS",NIH,,"$4,600,233"
Prostate Cancer,2017,NHGRI,1ZIAHG200325-13,,Finding Genes for Human Prostate Cancer,"OSTRANDER, ELAINE",NIH,,"$1,150,252"
Prostate Cancer,2017,NIDDK,1ZIAHL006003-10,,Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ,"RODGERS, GRIFFIN",NIH,,"$575,937"
Prostate Cancer,2017,NCI,261201700013C-0-0-1,,"IGF::OT::IGF (CHAMPIONS ONCOLOGY)To address the slow growth rate of prostate PDXs by eliminating logistical barriers through development of CDX (i.e., PDX from circulating tumor cells) models. PERIOD","KIPP, PETER","CHAMPIONS ONCOLOGY, INC.",NJ,"$1,999,931"
Prostate Cancer,2017,NCI,261201700015C-0-0-1,,IGF::OT::IGF SBIR Topic 355: A 3D Perfusable Platform for HTS Across Diverse Racial/Ethnic Cancer Specimens To generate racially diverse patient-derived xenograft (PDX)-derived prostate cancer culture,"SALEH, ANTHONY","MIMETAS US, INC.",MD,"$297,962"
Prostate Cancer,2017,NCI,261201700033C-0-0-1,,IGF::OT::IGF SBIR Phase II: Topic 338 - Predictive Biomarkers of Adverse Reactions to Prostrate Cancer Radiotherapy,"PETERSON-ROTH, ELIZABETH","L2 DIAGNOSTICS, LLC",CT,"$1,996,011"
Prostate Cancer,2017,NCI,ACN17001001-1-0-1,,Nutrient Interaction - Effects of I3C/DIM on T cell activities in Citrobacter rodentium-infected mouse model,"WILKINS, MARY",NIH,,"$65,000"
Prostate Cancer,2017,NCI,ACN17005001-1-0-1,,Early Detection Research Network (EDRN) Biomarker Reference Laboratory,"CREENAN, CDFM-A, MICHAEL",NIH,,"$493,479"
